{"gene":"TCF7","run_date":"2026-04-28T21:42:58","timeline":{"discoveries":[{"year":1991,"finding":"TCF-1 was identified as a T cell-specific transcription factor containing a single DNA-binding HMG box that binds to a sequence-specific motif (AACAAAG/TTCAAAG) in the CD3-epsilon and TCR alpha enhancers, and upon cotransfection into non-T cells can transactivate through its cognate motif.","method":"Protein purification, gel retardation, methylation interference, cotransfection reporter assays, cDNA cloning","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 — original identification with multiple orthogonal biochemical and functional assays, replicated across human and murine TCF-1","pmids":["1989880","1827138"],"is_preprint":false},{"year":1992,"finding":"The HMG boxes of TCF-1 and SRY recognize the heptamer motif A/T A/T C A A A G predominantly through nucleotide contacts in the minor groove of the DNA double helix, without major groove guanine contacts.","method":"Methylation interference footprinting, DEPC carbethoxylation interference, T→C and A→I substitution assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal biochemical footprinting methods defining the binding mechanism","pmids":["1639073"],"is_preprint":false},{"year":1991,"finding":"TCF-1 binds specifically to functional T cell-specific elements in the TCR beta (T beta 5) and TCR delta (T delta 7) enhancers, in addition to the CD3-epsilon and TCR alpha enhancers, defining a consensus binding motif A/T A/T C A A/G A G.","method":"Gel retardation analysis, sequence comparison","journal":"International immunology","confidence":"Medium","confidence_rationale":"Tier 2 — direct binding assays with purified recombinant protein across multiple enhancers","pmids":["1836958"],"is_preprint":false},{"year":1993,"finding":"TCF-1 (hLEF/TCF-1 alpha) contains a context-dependent transcriptional activation domain (amino acids 80–256, bipartite, proline-rich with tyrosine/serine motifs) separate from the HMG box that activates the TCR alpha enhancer in a T cell- and context-specific manner dependent on the neighboring TCF-2 binding site.","method":"GAL4 fusion transactivation assays, deletion and clustered amino acid substitution mutagenesis, reporter gene assays in T cell lines","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1 — reconstitution with mutagenesis mapping the activation domain, multiple controls","pmids":["8253387"],"is_preprint":false},{"year":1996,"finding":"TCF-1 is generated from two promoters and extensive alternative splicing producing isoforms of 25–55 kDa; inclusion of an extended N-terminal 116 amino acids (from an upstream promoter) confers similarity to LEF-1 and enables transactivation through the TCR alpha enhancer, establishing functional differences between isoforms.","method":"Western blotting, cDNA cloning, RACE, reporter transactivation assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 — direct molecular characterization with functional isoform comparison","pmids":["8622675"],"is_preprint":false},{"year":1999,"finding":"TCF-1 interacts with beta-catenin to become transcriptionally active in T cells, but unlike fibroblasts, inhibition of GSK-3beta (by lithium or PHA) is insufficient to activate TCF-dependent transcription in T lymphocytes, indicating a cell-type-specific difference in Wnt pathway regulation.","method":"Tcf reporter gene assays, dominant-negative GSK-3beta expression, lithium treatment in T cell lines vs. fibroblasts","journal":"International immunology","confidence":"Medium","confidence_rationale":"Tier 2 — functional reporter assays with multiple perturbations comparing cell types","pmids":["10221643"],"is_preprint":false},{"year":1999,"finding":"TCF-1 binds to two sites in the Ly49A NK cell receptor promoter and regulates its transcriptional activity; TCF-1 dosage determines the size of the Ly49A NK cell subset in vivo, establishing TCF-1 as a trans-acting regulator of clonal NK receptor acquisition.","method":"Promoter binding assays, in vivo TCF-1 dosage analysis in knockout mice","journal":"Immunity","confidence":"Medium","confidence_rationale":"Tier 2 — direct promoter binding combined with in vivo genetic dosage experiment","pmids":["10549625"],"is_preprint":false},{"year":2001,"finding":"The beta-catenin-binding domain of TCF-1 is required for survival of CD4+CD8+ double-positive thymocytes; loss of this domain leads to accelerated apoptosis correlated with decreased Bcl-xL expression, and this survival defect is rescued by a Bcl-2 transgene.","method":"Domain deletion knock-in mice, Bcl-2 transgene rescue, apoptosis assays, Bcl-xL expression analysis","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 1–2 — genetic rescue experiment with domain-specific allele and mechanistic link to Bcl-xL/Bcl-2","pmids":["11477404"],"is_preprint":false},{"year":2001,"finding":"Wnt1 and Wnt4 signals activate TCF-1-dependent transcription in thymocytes (demonstrated by Tcf-LacZ reporter mice); retroviral expression of soluble Wnt receptor mutants blocking Wnt signaling inhibits thymocyte development, and the beta-catenin–TCF-1 interaction is required for full thymocyte development.","method":"Tcf-LacZ reporter mice, retroviral Wnt receptor blockade, in vitro thymocyte culture","journal":"European journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo reporter and loss-of-function with Wnt pathway perturbation","pmids":["11265645"],"is_preprint":false},{"year":2005,"finding":"TCF-1 ensures survival of pre-TCR+ thymocytes through its N-terminal beta-catenin-binding domain; pre-TCR signaling induces TCF-1 expression and activates a Wnt/catenin/TCF reporter, while Wnt signals provide beta-catenin as coactivator, indicating cooperative integration of pre-TCR and Wnt signals for thymocyte survival.","method":"Domain-specific TCF-1 allele knock-in mice, Wnt/TCF reporter transgene, pre-TCR signaling analysis","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 — genetic epistasis with domain-specific allele and in vivo reporter","pmids":["15890681"],"is_preprint":false},{"year":2010,"finding":"TCF-1 is required for the establishment of CD8+ memory precursor T cells; its function in generating central memory CD8+ T cells depends on the catenin-binding domain and requires beta-catenin and gamma-catenin as coactivators.","method":"Tcf-1 knockout mice, LCMV infection model, secondary challenge, catenin-binding domain mutant analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — genetic KO with domain-specific analysis and clear phenotypic readout in vivo","pmids":["20457902"],"is_preprint":false},{"year":2011,"finding":"Forced expression of TCF-1 in bone marrow progenitors drives T-lineage cell development even in the absence of Notch1 signals, inducing expression of T cell genes including Gata3, Bcl11b, and TCR components; Notch signals induce TCF-1 which in turn imprints T cell fate.","method":"Retroviral forced expression in bone marrow progenitors, T cell development assays in vivo, gene expression profiling","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — gain-of-function in vivo with clear downstream gene activation and epistasis to Notch","pmids":["21814277"],"is_preprint":false},{"year":2011,"finding":"TCF-1 represses the IL-17 gene locus via epigenetic modifications (preventing histone hyperacetylation and H3K4 trimethylation at the IL-17 locus) during T cell development in the thymus; this chromatin silencing is established in thymocytes and maintained in peripheral T cells, restricting Th17 differentiation.","method":"Tcf-1 knockout mice, chromatin immunoprecipitation (histone modification), EAE model, reconstitution experiments","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP demonstrating epigenetic mechanism combined with KO and reconstitution","pmids":["21935461"],"is_preprint":false},{"year":2012,"finding":"TCF-1 directly represses LEF-1 expression in early thymocytes; loss of TCF-1 leads to aberrant LEF-1 upregulation and T cell malignancy resembling T-ALL, and conditional inactivation of Lef1 greatly delays or prevents T cell malignancy in Tcf7-/- mice.","method":"Tcf7 knockout mice, ChIP for TCF-1 binding at Lef1 locus, conditional Lef1 knockout rescue experiments","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 — direct binding evidence (ChIP) combined with genetic epistasis (double KO rescue)","pmids":["23103132"],"is_preprint":false},{"year":2012,"finding":"TCF-1 functions as a self-renewal/differentiation switch in multipotential hematopoietic precursors independently of autocrine Wnt signaling; TCF-1 binds RUNX1 promoter regions and is necessary for production of short but not long RUNX1 isoforms, and the two factors coordinately regulate self-renewal genes.","method":"RNA-seq, ChIP-seq, siRNA knockdown, reporter assays in EML hematopoietic cell line","journal":"PLoS genetics","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP-seq for TCF7 binding combined with KD and transcriptomic analysis","pmids":["22412390"],"is_preprint":false},{"year":2014,"finding":"TCF-1 and LEF-1 promote the CD4+ T cell fate by directly activating the Th-POK transcription factor; TCF-1 also physically interacts with Runx3 to cooperatively silence the Cd4 gene in CD8+ T cells, establishing distinct genetic mechanisms for CD4 vs. CD8 lineage decisions.","method":"DP-specific conditional knockout, ChIP, Co-immunoprecipitation (physical interaction with Runx3), reporter assays","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 — direct physical interaction by Co-IP, ChIP, and genetic KO with defined lineage phenotype","pmids":["24836425"],"is_preprint":false},{"year":2015,"finding":"TCF-1 directly binds the Bcl6 promoter to promote Bcl-6 expression and the Prdm1 5' regulatory region to repress Blimp1 expression, thereby initiating TFH differentiation by acting upstream of the Bcl-6–Blimp1 axis during acute viral infection.","method":"Chromatin immunoprecipitation (ChIP) at Bcl6 and Prdm1 loci, Tcf7 knockout mice, LCMV infection","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 1–2 — direct promoter binding by ChIP with genetic KO and clear mechanistic pathway","pmids":["26214740"],"is_preprint":false},{"year":2015,"finding":"LEF-1 and TCF-1 promote TFH differentiation by sustaining expression of cytokine receptors IL-6Rα and gp130, enhancing ICOS expression, and promoting Bcl6 expression, functioning upstream of the Bcl-6 transcriptional repressor circuit.","method":"Selective Lef1 and Tcf7 single and double conditional knockout mice, LEF-1 forced expression, gene expression analysis","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis with single and double KO combined with gain-of-function","pmids":["26214741"],"is_preprint":false},{"year":2015,"finding":"TCF-1 is required for efficient generation of all innate lymphoid cell (ILC) subsets; upregulation of TCF-1 marks early ILC-committed progenitors (EILPs) that efficiently give rise to NK cells and all helper ILC lineages but lack T and B cell potential.","method":"Tcf7 reporter mice, conditional knockout, adoptive transfer, lineage potential assays","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 — genetic KO with reporter-based progenitor identification and lineage tracing","pmids":["26280998"],"is_preprint":false},{"year":2018,"finding":"TCF-1 acts as a lineage-determining transcription factor that establishes the epigenetic identity of T cells by targeting silent chromatin and generating de novo chromatin accessibility; TCF-1 expression in fibroblasts opens chromatin at T cell-restricted gene loci even at regions with repressive marks.","method":"ATAC-seq across 8 T cell developmental stages, gain-of-function in fibroblasts, TCF-1 loss-of-function, single-cell chromatin profiling","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal genomic methods with gain- and loss-of-function in non-T cell context","pmids":["29466756"],"is_preprint":false},{"year":2018,"finding":"TCF-1 and HEB co-occupy ~7,000 genomic sites; TCF-1 displaces nucleosomes to promote chromatin accessibility, and TCF-1 inhibits Notch signaling to protect HEB from Notch-mediated proteasomal degradation, enabling cooperative regulation of the DP thymocyte transcriptional and epigenetic program.","method":"ChIP-seq, ATAC-seq, proteasome inhibition assays, Notch pathway perturbation, conditional KO","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal genomic methods with mechanistic protein stability assay","pmids":["30420627"],"is_preprint":false},{"year":2019,"finding":"TCF-1 mediates the bifurcation between terminal effector (KLRG1hi) and exhausted precursor (KLRG1lo) CD8 T cell fates during chronic infection by repressing terminal effectors, promoting Eomes over T-bet, and driving c-Myb expression to control Bcl-2 and survival; PD-1 stabilizes the TCF-1+ Tex precursor pool.","method":"scRNA-seq, lineage tracing, TCF-1 conditional KO, gene expression analysis during LCMV chronic infection","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 — genetic KO with scRNA-seq and lineage tracing establishing mechanistic pathway","pmids":["31606264"],"is_preprint":false},{"year":2019,"finding":"TCF-1 limits Tc17 (IL-17-producing CD8+ T) cell development through sequential suppression of MAF and RORγt transcription factors in double-positive thymocytes, in parallel with TCF-1-driven modulation of chromatin state.","method":"TCF-1 conditional KO (DP stage), RNA-seq, ATAC-seq, MAF/RORγt expression analysis","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 — genetic KO with genomic profiling defining the MAF-RORγt repression axis","pmids":["31142588"],"is_preprint":false},{"year":2019,"finding":"TCF-1 enforces ILC lineage commitment by binding pre-existing chromatin regulatory elements established in upstream lymphoid precursors in EILPs; TCF-1 is dispensable for specified EILPs but required for committed EILPs and restricts dendritic cell lineage potential.","method":"Single-cell transcriptomics, TCF-1 conditional KO, chromatin accessibility profiling (ATAC-seq), adoptive transfer lineage tracing","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 — single-cell genomics combined with genetic KO and lineage tracing","pmids":["31358996"],"is_preprint":false},{"year":2020,"finding":"Tcf7 promoter DNA methylation contributes to TCF-1 downregulation in exhausted CD8+ T cells, as demonstrated using an in vitro repeated stimulation exhaustion model where exhausted CTL showed Tcf7 promoter hypermethylation correlating with reduced TCF-1 expression.","method":"In vitro exhaustion model, promoter DNA methylation analysis, transcriptomic comparison to in vivo LCMV exhaustion","journal":"PLoS pathogens","confidence":"Medium","confidence_rationale":"Tier 2 — direct epigenetic measurement correlating Tcf7 promoter methylation with TCF-1 loss","pmids":["32579593"],"is_preprint":false},{"year":2021,"finding":"Regnase-1 directly targets Tcf7 mRNA; its deficiency augments TCF-1 protein expression, promoting formation of TCF-1+ precursor exhausted T cells with upregulated memory and exhaustion markers, and enhancing CAR-T-cell expansion, persistence, and memory-like cell formation.","method":"Regnase-1 KO mouse model, phenotypic/transcriptional/epigenetic profiling, human CAR-T xenograft model","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 — direct mRNA targeting with functional consequences in mouse and human models","pmids":["33690816"],"is_preprint":false},{"year":2021,"finding":"TCF-1 primarily suppresses transcription of genes co-bound by Foxp3 in regulatory T cells; TCF-1 deficiency in Tregs promotes alternative TH17-associated signaling pathways, gut-homing properties, and impairs control of CD4+ T cell polarization and inflammation without altering the core Treg transcriptional signature.","method":"Treg-specific TCF-1 conditional KO, scRNA-seq, ChIP-seq, tumor models","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 — Treg-specific KO with scRNA-seq and ChIP-seq defining the co-bound Foxp3 gene repression mechanism","pmids":["34385712"],"is_preprint":false},{"year":2022,"finding":"TCF-1 co-occupancy with the architectural protein CTCF alters topologically associating domain (TAD) structure in T cell progenitors, creating long-range chromatin interactions between previously insulated regulatory elements and target genes; this is linked to H3K27ac deposition and NIPBL recruitment at active enhancers.","method":"Hi-C, ChIP-seq, ATAC-seq, TCF-1 gain- and loss-of-function in T cell progenitors","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 1–2 — 3D genome analysis by Hi-C with gain- and loss-of-function and mechanistic chromatin factor recruitment","pmids":["35726060"],"is_preprint":false},{"year":2010,"finding":"Runx2 transcriptionally activates the Tcf7 promoter in chondrocytes (0.3 kb proximal promoter region responsible for Runx2-dependent activation); dominant-negative Tcf7 in Col2a1-expressing chondrocytes causes dwarfism, retarded mineralization, and reduced chondrocyte proliferation, indicating TCF-1 is required for chondrocyte maturation and proliferation downstream of Runx2.","method":"Microarray, reporter assays with Tcf7 promoter deletion constructs, dominant-negative transgenic mice, BrdU labeling, in situ hybridization","journal":"Journal of bone and mineral metabolism","confidence":"Medium","confidence_rationale":"Tier 2 — promoter reporter assays combined with dominant-negative transgenic phenotype","pmids":["20890621"],"is_preprint":false},{"year":2009,"finding":"In normal colon cells, a dominant-negative TCF-1 isoform (dnTCF-1) is equally distributed between nuclear and cytoplasmic compartments, whereas in colon cancer cells TCF-1 is predominantly cytoplasmic due to active nuclear export directed by an autocrine Wnt ligand that requires CaMKII activity for secretion.","method":"Immunofluorescence, nuclear export inhibition, CaMKII inhibition, Wnt ligand blocking in colon cancer vs. normal cells","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 — direct localization experiments with pharmacological dissection of the export mechanism","pmids":["19749792"],"is_preprint":false},{"year":2010,"finding":"IL-4 signaling via STAT6 downregulates TCF-1 expression in human naive CD4+ T cells, preferentially suppressing the shorter dominant-negative TCF-1 isoforms; STAT6 directly binds the TCF-1 regulatory region as shown by EMSA and ChIP.","method":"EMSA, ChIP, STAT6 knockdown, qPCR, cytokine treatment of primary human T cells","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — direct binding evidence (EMSA, ChIP) with KD mechanistic follow-up","pmids":["20980261"],"is_preprint":false},{"year":2015,"finding":"miR-22-3p binds to the 3' UTR of TCF7 mRNA and downregulates its expression; knockdown of TCF7 in hepatocytes upregulates gluconeogenic genes, and in vivo antagomiR-mediated silencing of miR-22-3p restores hepatic TCF7 and reduces gluconeogenesis in diabetic mice.","method":"Luciferase 3'UTR reporter assay, siRNA knockdown, antagomiR in vivo, gluconeogenic gene expression","journal":"Diabetes","confidence":"Medium","confidence_rationale":"Tier 2 — direct 3'UTR binding validated by reporter assay with in vivo rescue","pmids":["26193896"],"is_preprint":false},{"year":2017,"finding":"The deubiquitinase Uch37 interacts with TCF-1 (Tcf7) and its deubiquitinase activity is required for Tcf7 association with target gene promoters (chromatin occupancy), without affecting TCF-1 protein stability, thereby activating Wnt/beta-catenin target gene expression in Xenopus embryos and human liver cancer cells.","method":"Co-immunoprecipitation, ChIP in Xenopus embryo and HCC cells, Uch37 knockdown/overexpression, deubiquitinase activity mutants","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 — reciprocal Co-IP with functional ChIP demonstrating chromatin occupancy mechanism","pmids":["28198400"],"is_preprint":false},{"year":2015,"finding":"TCF7 is a direct target of miR-34a; ectopic miR-34a inhibits bone metastasis in Ras-activated prostate cancer and reduces TCF7-driven WNT signaling; TCF7 itself has oncogenic properties in prostate cancer cells promoting androgen-independent proliferation.","method":"miR-34a ectopic expression, xenograft model, WNT gene signature analysis, TCF7 expression correlation with miR-34a","journal":"Oncotarget","confidence":"Low","confidence_rationale":"Tier 3 — functional cancer model with indirect evidence of TCF7 as miR-34a target; no direct 3'UTR validation described","pmids":["25436980"],"is_preprint":false},{"year":2015,"finding":"AF1q specifically binds to TCF7 protein in the Wnt signaling pathway and results in transcriptional activation of CD44 and downstream TCF7/LEF1 targets; AF1q promotes breast cancer proliferation, migration, mammosphere formation, and metastasis through the AF1q/TCF7/CD44 axis.","method":"Co-immunoprecipitation (AF1q–TCF7 interaction), reporter/gene expression assays, xenograft models","journal":"Oncotarget","confidence":"Low","confidence_rationale":"Tier 3 — single Co-IP identifying novel binding partner with downstream functional assays","pmids":["26079538"],"is_preprint":false},{"year":2018,"finding":"TCF-1 functions in brown adipocytes to modulate Gprc6a and Ucp1 promoter activation independent of beta-catenin, requiring PRDM16 and the histone demethylase LSD1 as coactivators, as part of an osteocalcin-GPRC6A-TCF7 feedback axis in thermogenesis.","method":"Overexpression and knockdown of Tcf7, promoter reporter assays, co-factor interaction studies in brown adipocytes","journal":"Molecular and cellular biology","confidence":"Low","confidence_rationale":"Tier 3 — promoter assays with beta-catenin independence shown, but single study with limited mechanistic detail on PRDM16/LSD1 interaction","pmids":["29358218"],"is_preprint":false},{"year":2014,"finding":"TCF-1-mediated Wnt signaling activates alpha-defensin HD-5 and HD-6 transcription in Paneth cells via three distinct TCF binding sites in the defensin promoters; binding of TCF-1 to these motifs was confirmed by EMSA, and TCF-1 cooperates with beta-catenin to activate transcription.","method":"Reporter gene assays, EMSA, promoter binding analysis, Tcf-1 knockout mice (cryptdin expression)","journal":"American journal of physiology. Gastrointestinal and liver physiology","confidence":"Medium","confidence_rationale":"Tier 2 — EMSA and reporter assay with in vivo knockout validation","pmids":["24994854"],"is_preprint":false},{"year":2020,"finding":"A 1 kb regulatory element containing a Notch binding site is crucial for initiation of Tcf7 expression in T cells and innate lymphoid cells, but different transcriptional controllers use this same element in T cells vs. ILCs; Notch binding is required for Tcf7 initiation in T cells but not in ILCs.","method":"Regulatory element deletion analysis, reporter mice, Notch binding site mutation, Tcf7 expression in multiple lineages","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 2 — regulatory element deletion with lineage-specific mechanistic distinction","pmids":["32265924"],"is_preprint":false},{"year":2022,"finding":"Single-cell CRISPR disruption of Tcf7 in early T cell progenitors reveals a kinetic tug-of-war with progenitor factors Spi1/Bcl11a, where Tcf7 functions before T lineage commitment to regulate developmental speed and cell fate choices at the DN1 stage.","method":"Single-cell CRISPR disruption, scRNA-seq, synchronized in vitro differentiation","journal":"Science immunology","confidence":"Medium","confidence_rationale":"Tier 2 — single-cell CRISPR KO with transcriptomic readout defining epistatic relationships","pmids":["35594339"],"is_preprint":false},{"year":2020,"finding":"Tcf7hi effector-phase CD8+ T cells show no evidence of prior cytolytic differentiation and quantitatively give rise to central memory T cells based on lineage tracing; mechanistically, Tcf1 counteracts Tcf7hi cell differentiation and sustains expression of conserved adult stem-cell genes critical for CD8 T cell stemness.","method":"Lineage tracing, scRNA-seq, Tcf7 conditional KO, gene expression analysis during acute infection","journal":"Immunity","confidence":"Medium","confidence_rationale":"Tier 2 — lineage tracing combined with KO defining mechanistic role in stemness maintenance","pmids":["33128876"],"is_preprint":false},{"year":2021,"finding":"CRISPR-Cas9 editing of TCF-1 in human primary T cells directly reduces expansion capacity, demonstrating a cell-intrinsic role for TCF-1 in regulating the secondary expansion (stem-like memory) property of HIV-specific CD8+ T cells.","method":"CRISPR-Cas9 editing of TCF-1 in human primary T cells, expansion assays","journal":"JCI insight","confidence":"Medium","confidence_rationale":"Tier 2 — direct CRISPR KO in primary human cells with functional expansion readout","pmids":["33351785"],"is_preprint":false},{"year":2022,"finding":"TGF-β signaling maintains the stem-like state and quiescence of PD-1+ TCF-1+ CD8 T cells during chronic LCMV infection; TGF-β regulates the unique transcriptional program of these cells including upregulation of inhibitory receptors specifically expressed on them, and promotes terminal differentiation of exhausted CD8 T cells by suppressing the effector program.","method":"TGF-β receptor conditional KO in virus-specific CD8 T cells, transcriptomic analysis, LCMV chronic infection model","journal":"The Journal of experimental medicine","confidence":"Medium","confidence_rationale":"Tier 2 — cell-specific KO with transcriptomic definition of the TCF-1+ stem-like subset regulation","pmids":["35980386"],"is_preprint":false},{"year":2021,"finding":"IL-10R–STAT3 signaling maintains the PD-1int TCF-1+ CD8+ T cell population; inhibition of IL-10R signaling alters chromatin accessibility and disrupts NFAT/AP-1 cooperativity, promoting an NFAT-associated exhaustion program and accumulation of PD-1hi cells.","method":"Il10rb/Stat3 conditional KO, scRNA-seq, ATAC-seq, CLL mouse model","journal":"Immunity","confidence":"Medium","confidence_rationale":"Tier 2 — cell-specific KO with chromatin accessibility and transcriptomic analysis","pmids":["34879221"],"is_preprint":false},{"year":2023,"finding":"IL-33–ST2 signaling is pivotal for expansion and maintenance of stem-like TCF-1+ CD8+ T cells during chronic viral infection; ST2-deficient CD8+ T cells show biased terminal differentiation and premature loss of Tcf-1, effects rescued by blockade of type I interferon; IL-33 broadly augments chromatin accessibility in TCF-1+ stem-like cells.","method":"ST2-KO mice, chronic LCMV infection, ATAC-seq, type I IFN blockade rescue, lineage tracing","journal":"Immunity","confidence":"Medium","confidence_rationale":"Tier 2 — genetic KO with chromatin profiling and cytokine pathway rescue","pmids":["36809763"],"is_preprint":false},{"year":2017,"finding":"The androgen receptor suppresses TCF7 expression partly through induction of miR-1 which targets TCF7 mRNA; TCF7 overexpression or disruption of miR-1 function promotes androgen-independent proliferation in prostate cancer, demonstrating TCF7 as an oncogenic factor controlled by the AR-miR-1 axis.","method":"miR-1 overexpression, TCF7 overexpression/knockdown, xenograft model, clinical dataset analysis","journal":"Prostate cancer and prostatic diseases","confidence":"Low","confidence_rationale":"Tier 3 — functional cancer model with indirect miRNA-TCF7 relationship; miR-1 3'UTR validation not explicitly detailed in abstract","pmids":["28220803"],"is_preprint":false}],"current_model":"TCF-1 (encoded by TCF7) is a T cell-specific HMG-box transcription factor that binds DNA primarily through minor groove contacts at AACAAAG motifs, activates or represses target genes through beta-catenin-dependent and -independent mechanisms, establishes chromatin accessibility and epigenetic identity at T cell lineage loci (including by displacing nucleosomes and organizing 3D genome architecture via CTCF co-occupancy), acts as a lineage-determining factor for T cells and ILCs by enforcing lineage-specific gene programs while suppressing alternative fates (repressing LEF-1, IL-17, MAF/RORγt, and alternative lineage regulators), and sustains stem-like CD8+ T cell properties in chronic infection and tumors by maintaining TCF-1+ precursor exhausted T cells through Wnt/beta-catenin signaling, epigenetic maintenance, and responses to cytokine cues including IL-33, TGF-β, and IL-10R–STAT3 pathways."},"narrative":{"teleology":[{"year":1991,"claim":"The identity of the T cell-specific factor recognizing TCR/CD3 enhancers was unknown; cloning and biochemical characterization of TCF-1 revealed a single HMG-box protein that binds AACAAAG motifs and transactivates in T cells, establishing TCF-1 as the founding TCR enhancer-binding factor.","evidence":"Protein purification, gel retardation, methylation interference, cotransfection reporter assays, cDNA cloning in human and murine T cells","pmids":["1989880","1827138","1836958"],"confidence":"High","gaps":["Three-dimensional structure of TCF-1 HMG box on DNA not yet determined","Mechanism of T cell-specific expression not defined"]},{"year":1992,"claim":"How TCF-1/HMG-box proteins contact DNA was unclear; footprinting showed recognition occurs predominantly through minor groove contacts without major groove guanine interactions, distinguishing this from classical transcription factor binding modes.","evidence":"Methylation interference, DEPC carbethoxylation, nucleotide substitution assays","pmids":["1639073"],"confidence":"High","gaps":["Structural basis for sequence selectivity via minor groove not resolved at atomic level"]},{"year":1993,"claim":"Whether TCF-1 has an autonomous activation domain was unresolved; mapping identified a bipartite, context-dependent activation domain (aa 80–256) that functions only with cooperating elements, and alternative promoter usage was shown to generate functionally distinct long and short isoforms.","evidence":"GAL4 fusion mutagenesis, reporter assays in T cell lines, cDNA cloning and RACE","pmids":["8253387","8622675"],"confidence":"High","gaps":["Cofactors mediating context-dependent activation not identified","Relative isoform abundance across developmental stages incompletely mapped"]},{"year":2001,"claim":"The functional requirement for β-catenin interaction was unknown; domain-specific knock-in mice demonstrated that the β-catenin-binding domain is essential for DP thymocyte survival via Bcl-xL, and that Wnt1/Wnt4 ligands activate TCF-1-dependent transcription in thymocytes.","evidence":"β-catenin-binding domain deletion knock-in mice, Bcl-2 transgene rescue, Tcf-LacZ reporter mice, retroviral Wnt blockade","pmids":["11477404","11265645"],"confidence":"High","gaps":["Whether γ-catenin compensates in vivo not tested","Upstream Wnt ligand source in thymic microenvironment not defined"]},{"year":2010,"claim":"Whether TCF-1 functions in CD8+ memory formation was untested; knockout and domain-mutant studies showed TCF-1's β-catenin-binding domain is required for central memory CD8+ T cell generation, with β-catenin and γ-catenin as coactivators.","evidence":"Tcf-1 KO mice, LCMV infection, secondary challenge, catenin-binding domain mutant analysis","pmids":["20457902"],"confidence":"High","gaps":["Direct TCF-1 target genes in memory precursors not identified","Relative contribution of β- vs. γ-catenin not dissected"]},{"year":2011,"claim":"Whether TCF-1 is sufficient to initiate T cell fate was unknown; forced TCF-1 expression in bone marrow progenitors drove T lineage gene programs (Gata3, Bcl11b) even without Notch, placing TCF-1 downstream of Notch as a T cell fate-determining factor, while also revealing epigenetic repression of IL-17 loci.","evidence":"Retroviral gain-of-function in BM progenitors, in vivo development assays, ChIP for histone modifications at IL-17 locus in KO mice","pmids":["21814277","21935461"],"confidence":"High","gaps":["Whether TCF-1 alone is sufficient without any other Notch-induced factors unclear","Mechanism of epigenetic silencing (writer/eraser recruitment) not identified"]},{"year":2012,"claim":"How TCF-1 loss causes T-ALL was unexplained; ChIP and genetic epistasis demonstrated TCF-1 directly represses LEF-1 transcription, and aberrant LEF-1 upregulation drives T cell malignancy, which is rescued by conditional Lef1 deletion.","evidence":"ChIP at Lef1 locus, Tcf7 KO mice developing T-ALL, conditional Lef1 KO rescue","pmids":["23103132"],"confidence":"High","gaps":["Whether LEF-1 is the sole oncogenic driver or cooperates with other derepressed genes not fully resolved"]},{"year":2014,"claim":"How TCF-1 controls CD4/CD8 lineage choice was mechanistically unclear; TCF-1 was shown to directly activate ThPOK for CD4 fate and physically interact with Runx3 to silence Cd4 in CD8 cells, revealing dual mechanisms for lineage bifurcation.","evidence":"DP-specific conditional KO, ChIP, Co-IP for TCF-1–Runx3 interaction, reporter assays","pmids":["24836425"],"confidence":"High","gaps":["Whether the TCF-1–Runx3 interaction is direct or bridged by other factors not resolved by Co-IP alone"]},{"year":2015,"claim":"TCF-1's role in T follicular helper differentiation was unknown; ChIP demonstrated direct TCF-1 binding at Bcl6 and Prdm1 loci to activate Bcl-6 and repress Blimp1, while also sustaining IL-6Rα/gp130 and ICOS expression, positioning TCF-1 as the initiator of the TFH program. Concurrently, TCF-1 was established as essential for all ILC subsets by marking early ILC-committed progenitors.","evidence":"ChIP at Bcl6/Prdm1 loci, Tcf7 KO with LCMV infection, Tcf7 reporter mice for ILC progenitor identification, conditional KO lineage assays","pmids":["26214740","26214741","26280998"],"confidence":"High","gaps":["Whether TCF-1 directly or indirectly regulates Bcl6 in TFH vs. GC-B cells not distinguished","Cofactors at ILC progenitor stage not defined"]},{"year":2018,"claim":"Whether TCF-1 functions as a pioneer factor to establish chromatin accessibility was untested; ATAC-seq across developmental stages and gain-of-function in fibroblasts showed TCF-1 opens chromatin de novo at T cell-restricted loci, displaces nucleosomes, and protects HEB from Notch-mediated degradation at co-occupied sites.","evidence":"ATAC-seq, ChIP-seq, TCF-1 ectopic expression in fibroblasts, proteasome inhibition assays, conditional KO","pmids":["29466756","30420627"],"confidence":"High","gaps":["Whether TCF-1 directly contacts and displaces histones or requires remodeling machinery not determined","Genome-wide nucleosome displacement kinetics not measured"]},{"year":2019,"claim":"How TCF-1 governs the bifurcation between terminal effector and exhausted precursor CD8+ T cells was unclear; scRNA-seq and lineage tracing revealed TCF-1 represses terminal effector fate, promotes Eomes and c-Myb for survival, and limits Tc17 development by sequentially suppressing MAF and RORγt. In ILCs, TCF-1 binds pre-existing regulatory elements to enforce lineage commitment while restricting DC potential.","evidence":"scRNA-seq, lineage tracing, TCF-1 conditional KO in chronic LCMV and DP thymocytes, ATAC-seq, adoptive transfer","pmids":["31606264","31142588","31358996"],"confidence":"High","gaps":["Direct TCF-1 target genes maintaining the exhausted precursor state not comprehensively defined","Whether MAF/RORγt suppression is via direct promoter binding or indirect chromatin remodeling not fully resolved"]},{"year":2021,"claim":"The cytokine signals and chromatin mechanisms sustaining TCF-1+ stem-like CD8+ T cells were incompletely understood; multiple studies revealed IL-10R–STAT3 maintains the TCF-1+ pool by preserving NFAT/AP-1 cooperativity, Regnase-1 post-transcriptionally limits Tcf7 mRNA abundance, and TCF-1 suppresses alternative TH17 programs at Foxp3 co-bound genes in Tregs.","evidence":"Il10rb/Stat3 conditional KO with ATAC-seq, Regnase-1 KO with CAR-T functional assays, Treg-specific TCF-1 KO with scRNA-seq and ChIP-seq","pmids":["34879221","33690816","34385712"],"confidence":"Medium","gaps":["Whether IL-10R–STAT3 acts directly on Tcf7 transcription or indirectly through chromatin remodeling not resolved","Regnase-1 binding site on Tcf7 mRNA not mapped precisely"]},{"year":2022,"claim":"How TCF-1 reorganizes 3D genome architecture was unknown; Hi-C revealed TCF-1 co-occupancy with CTCF alters TAD boundaries, creating long-range enhancer-gene contacts with NIPBL recruitment and H3K27ac deposition, while single-cell CRISPR showed TCF-1 acts before T lineage commitment in a kinetic competition with progenitor factors Spi1/Bcl11a.","evidence":"Hi-C, ChIP-seq, ATAC-seq, gain/loss-of-function in T cell progenitors; single-cell CRISPR disruption with scRNA-seq","pmids":["35726060","35594339"],"confidence":"High","gaps":["Whether TCF-1 directly recruits NIPBL/cohesin or this is an indirect consequence of chromatin opening","Relative timing of TCF-1 vs. CTCF binding at remodeled TADs not established"]},{"year":2023,"claim":"Whether specific cytokine signals maintain TCF-1+ stem-like cells in chronic infection remained incompletely mapped; IL-33–ST2 signaling was shown to be pivotal for expansion of stem-like TCF-1+ CD8+ T cells, with ST2 deficiency causing premature TCF-1 loss rescued by type I IFN blockade, and TGF-β was shown to maintain quiescence of TCF-1+ cells.","evidence":"ST2-KO mice with chronic LCMV, ATAC-seq, IFN blockade rescue; TGF-β receptor conditional KO with transcriptomics","pmids":["36809763","35980386"],"confidence":"Medium","gaps":["Whether IL-33 directly induces Tcf7 transcription or acts through chromatin remodeling intermediates","Integration of IL-33, TGF-β, and IL-10R signals at the single-cell level not resolved"]},{"year":null,"claim":"Major open questions include: the structural basis for TCF-1's pioneer-like chromatin remodeling activity, the complete set of direct transcriptional targets maintaining stem-like CD8+ T cells and ILC progenitors, how multiple cytokine inputs (IL-33, TGF-β, IL-10R) are integrated to regulate Tcf7 expression and TCF-1+ cell fate, and whether TCF-1's 3D genome reorganization via CTCF involves direct cohesin recruitment.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structural model of TCF-1 in complex with nucleosomal DNA","Comprehensive direct target gene catalog in stem-like T cells lacking","Signal integration logic at Tcf7 regulatory elements not defined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,1,2,6,16,36]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,3,11,13,16,19,26]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,3,19,29]},{"term_id":"GO:0005694","term_label":"chromosome","supporting_discovery_ids":[19,20,27]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[5,7,8,9,32]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[3,11,13,16,19,26]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[12,19,20,27]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[10,11,18,21,40]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[7,9,11,15,38]}],"complexes":["β-catenin–TCF-1 transcriptional complex"],"partners":["CTNNB1","CTCF","RUNX3","HEB","FOXP3","LEF1","UCH37"],"other_free_text":[]},"mechanistic_narrative":"TCF-1 (encoded by TCF7) is a sequence-specific HMG-box transcription factor that serves as a master regulator of T cell and innate lymphoid cell (ILC) lineage identity, chromatin architecture, and stem-like T cell maintenance. TCF-1 binds the minor groove of DNA at AACAAAG motifs in T cell receptor and other lymphoid gene enhancers, activating or repressing transcription through both β-catenin-dependent and -independent mechanisms; its N-terminal β-catenin-binding domain is required for thymocyte survival via Bcl-xL induction and for CD8+ memory T cell generation [PMID:1989880, PMID:11477404, PMID:20457902]. As a pioneer-like factor, TCF-1 displaces nucleosomes to establish de novo chromatin accessibility at T cell-restricted loci, co-occupies genomic sites with CTCF to reorganize three-dimensional genome topology, and epigenetically silences alternative lineage programs including IL-17/RORγt, MAF, and LEF-1, whose aberrant upregulation in TCF-1-deficient mice causes T-ALL [PMID:29466756, PMID:35726060, PMID:23103132, PMID:31142588]. TCF-1 also sustains stem-like TCF-1⁺ precursor exhausted CD8⁺ T cells during chronic infection and cancer—maintained by TGF-β, IL-33–ST2, and IL-10R–STAT3 signals—and initiates T follicular helper differentiation by directly activating Bcl6 and repressing Blimp1 [PMID:31606264, PMID:36809763, PMID:26214740]."},"prefetch_data":{"uniprot":{"accession":"P36402","full_name":"Transcription factor 7","aliases":["T-cell-specific transcription factor 1","T-cell factor 1","TCF-1"],"length_aa":384,"mass_kda":41.6,"function":"Transcriptional activator involved in T-cell lymphocyte differentiation. Necessary for the survival of CD4(+) CD8(+) immature thymocytes. Isoforms lacking the N-terminal CTNNB1 binding domain cannot fulfill this role. Binds to the T-lymphocyte-specific enhancer element (5'-WWCAAAG-3') found in the promoter of the CD3E gene. Represses expression of the T-cell receptor gamma gene in alpha-beta T-cell lineages (By similarity). Required for the development of natural killer receptor-positive lymphoid tissue inducer T-cells (By similarity). TLE1, TLE2, TLE3 and TLE4 repress transactivation mediated by TCF7 and CTNNB1. May also act as feedback transcriptional repressor of CTNNB1 and TCF7L2 target genes","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/P36402/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TCF7","classification":"Not Classified","n_dependent_lines":12,"n_total_lines":1208,"dependency_fraction":0.009933774834437087},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/TCF7","total_profiled":1310},"omim":[{"mim_id":"616333","title":"WNT SIGNALING PATHWAY ACTIVATING NONCODING RNA; WSPAR","url":"https://www.omim.org/entry/616333"},{"mim_id":"612034","title":"APC2 REGULATOR OF WNT SIGNALING PATHWAY 2; APC2","url":"https://www.omim.org/entry/612034"},{"mim_id":"611784","title":"GENERAL TRANSCRIPTION FACTOR 3C, POLYPEPTIDE 6; GTF3C6","url":"https://www.omim.org/entry/611784"},{"mim_id":"611731","title":"APC REGULATOR OF WNT SIGNALING PATHWAY; APC","url":"https://www.omim.org/entry/611731"},{"mim_id":"606359","title":"WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 3A; WNT3A","url":"https://www.omim.org/entry/606359"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Nucleoplasm","reliability":"Enhanced"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"lymphoid tissue","ntpm":518.8}],"url":"https://www.proteinatlas.org/search/TCF7"},"hgnc":{"alias_symbol":["TCF-1"],"prev_symbol":[]},"alphafold":{"accession":"P36402","domains":[{"cath_id":"1.10.30.10","chopping":"269-334","consensus_level":"medium","plddt":94.0256,"start":269,"end":334}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P36402","model_url":"https://alphafold.ebi.ac.uk/files/AF-P36402-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P36402-F1-predicted_aligned_error_v6.png","plddt_mean":57.09},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TCF7","jax_strain_url":"https://www.jax.org/strain/search?query=TCF7"},"sequence":{"accession":"P36402","fasta_url":"https://rest.uniprot.org/uniprotkb/P36402.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P36402/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P36402"}},"corpus_meta":[{"pmid":"31606264","id":"PMC_31606264","title":"TCF-1-Centered Transcriptional Network Drives an Effector versus Exhausted CD8 T Cell-Fate Decision.","date":"2019","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/31606264","citation_count":555,"is_preprint":false},{"pmid":"1989880","id":"PMC_1989880","title":"Identification and cloning of TCF-1, a T lymphocyte-specific transcription factor containing a sequence-specific HMG box.","date":"1991","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/1989880","citation_count":512,"is_preprint":false},{"pmid":"21814277","id":"PMC_21814277","title":"A critical role for TCF-1 in T-lineage specification and differentiation.","date":"2011","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/21814277","citation_count":336,"is_preprint":false},{"pmid":"20457902","id":"PMC_20457902","title":"Essential role of the Wnt pathway effector Tcf-1 for the establishment of functional CD8 T cell memory.","date":"2010","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/20457902","citation_count":304,"is_preprint":false},{"pmid":"26214741","id":"PMC_26214741","title":"LEF-1 and TCF-1 orchestrate T(FH) differentiation by regulating differentiation circuits upstream of the transcriptional repressor Bcl6.","date":"2015","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26214741","citation_count":286,"is_preprint":false},{"pmid":"26280998","id":"PMC_26280998","title":"TCF-1 upregulation identifies early innate lymphoid progenitors in the bone marrow.","date":"2015","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26280998","citation_count":241,"is_preprint":false},{"pmid":"8223271","id":"PMC_8223271","title":"Differential expression of the HMG box factors TCF-1 and LEF-1 during murine embryogenesis.","date":"1993","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/8223271","citation_count":228,"is_preprint":false},{"pmid":"34534439","id":"PMC_34534439","title":"Conventional type I dendritic cells maintain a reservoir of proliferative tumor-antigen specific TCF-1+ CD8+ T cells in tumor-draining lymph nodes.","date":"2021","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/34534439","citation_count":222,"is_preprint":false},{"pmid":"11477404","id":"PMC_11477404","title":"The beta-catenin--TCF-1 pathway ensures CD4(+)CD8(+) thymocyte survival.","date":"2001","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11477404","citation_count":201,"is_preprint":false},{"pmid":"1639073","id":"PMC_1639073","title":"Sequence-specific interaction of the HMG box proteins TCF-1 and SRY occurs within the minor groove of a Watson-Crick double helix.","date":"1992","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/1639073","citation_count":199,"is_preprint":false},{"pmid":"26214740","id":"PMC_26214740","title":"The transcription factor TCF-1 initiates the differentiation of T(FH) cells during acute viral infection.","date":"2015","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26214740","citation_count":198,"is_preprint":false},{"pmid":"9780167","id":"PMC_9780167","title":"Critical involvement of Tcf-1 in expansion of thymocytes.","date":"1998","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/9780167","citation_count":187,"is_preprint":false},{"pmid":"8622675","id":"PMC_8622675","title":"Extensive alternative splicing and dual promoter usage generate Tcf-1 protein isoforms with differential transcription control properties.","date":"1996","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8622675","citation_count":175,"is_preprint":false},{"pmid":"29466756","id":"PMC_29466756","title":"Lineage-Determining Transcription Factor TCF-1 Initiates the Epigenetic Identity of T Cells.","date":"2018","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/29466756","citation_count":169,"is_preprint":false},{"pmid":"34172072","id":"PMC_34172072","title":"Circ3823 contributes to growth, metastasis and angiogenesis of colorectal cancer: involvement of miR-30c-5p/TCF7 axis.","date":"2021","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/34172072","citation_count":157,"is_preprint":false},{"pmid":"8253387","id":"PMC_8253387","title":"The hLEF/TCF-1 alpha HMG protein contains a context-dependent transcriptional activation domain that induces the TCR alpha enhancer in T cells.","date":"1993","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/8253387","citation_count":157,"is_preprint":false},{"pmid":"11265645","id":"PMC_11265645","title":"Wnt signaling is required for thymocyte development and activates Tcf-1 mediated transcription.","date":"2001","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11265645","citation_count":154,"is_preprint":false},{"pmid":"33128876","id":"PMC_33128876","title":"Central memory CD8+ T cells derive from stem-like Tcf7hi effector cells in the absence of cytotoxic differentiation.","date":"2020","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/33128876","citation_count":153,"is_preprint":false},{"pmid":"23103132","id":"PMC_23103132","title":"The TCF-1 and LEF-1 transcription factors have cooperative and opposing roles in T cell development and malignancy.","date":"2012","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/23103132","citation_count":152,"is_preprint":false},{"pmid":"24836425","id":"PMC_24836425","title":"TCF-1 and LEF-1 act upstream of Th-POK to promote the CD4(+) T cell fate and interact with Runx3 to silence Cd4 in CD8(+) T cells.","date":"2014","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24836425","citation_count":142,"is_preprint":false},{"pmid":"18065431","id":"PMC_18065431","title":"Insertional mutagenesis by the Tol2 transposon-mediated enhancer trap approach generated mutations in two developmental genes: tcf7 and synembryn-like.","date":"2008","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/18065431","citation_count":139,"is_preprint":false},{"pmid":"1827138","id":"PMC_1827138","title":"Cloning of murine TCF-1, a T cell-specific transcription factor interacting with functional motifs in the CD3-epsilon and T cell receptor alpha enhancers.","date":"1991","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/1827138","citation_count":137,"is_preprint":false},{"pmid":"2083253","id":"PMC_2083253","title":"Purification of TCF-1 alpha, a T-cell-specific transcription factor that activates the T-cell receptor C alpha gene enhancer in a context-dependent manner.","date":"1990","source":"The New biologist","url":"https://pubmed.ncbi.nlm.nih.gov/2083253","citation_count":117,"is_preprint":false},{"pmid":"24038093","id":"PMC_24038093","title":"TCF-1 controls ILC2 and NKp46+RORγt+ innate lymphocyte differentiation and protection in intestinal inflammation.","date":"2013","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/24038093","citation_count":112,"is_preprint":false},{"pmid":"9064330","id":"PMC_9064330","title":"Involvement of transcription factors TCF-1 and GATA-3 in the initiation of the earliest step of T cell development in the thymus.","date":"1996","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/9064330","citation_count":112,"is_preprint":false},{"pmid":"34879221","id":"PMC_34879221","title":"Interleukin-10 receptor signaling promotes the maintenance of a PD-1int TCF-1+ CD8+ T cell population that sustains anti-tumor immunity.","date":"2021","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/34879221","citation_count":98,"is_preprint":false},{"pmid":"31358996","id":"PMC_31358996","title":"The transcription factor TCF-1 enforces commitment to the innate lymphoid cell lineage.","date":"2019","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31358996","citation_count":97,"is_preprint":false},{"pmid":"15365098","id":"PMC_15365098","title":"IL-7 receptor signals inhibit expression of transcription factors TCF-1, LEF-1, and RORgammat: impact on thymocyte development.","date":"2004","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15365098","citation_count":97,"is_preprint":false},{"pmid":"35472220","id":"PMC_35472220","title":"In vivo labeling reveals continuous trafficking of TCF-1+ T cells between tumor and lymphoid tissue.","date":"2022","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35472220","citation_count":92,"is_preprint":false},{"pmid":"33913198","id":"PMC_33913198","title":"Role of TCF-1 in differentiation, exhaustion, and memory of CD8+ T cells: A review.","date":"2021","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/33913198","citation_count":87,"is_preprint":false},{"pmid":"22412390","id":"PMC_22412390","title":"Tcf7 is an important regulator of the switch of self-renewal and differentiation in a multipotential hematopoietic cell line.","date":"2012","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22412390","citation_count":85,"is_preprint":false},{"pmid":"31734149","id":"PMC_31734149","title":"Control of Lymphocyte Fate, Infection, and Tumor Immunity by TCF-1.","date":"2019","source":"Trends in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31734149","citation_count":84,"is_preprint":false},{"pmid":"25436980","id":"PMC_25436980","title":"MicroRNA-34a regulates WNT/TCF7 signaling and inhibits bone metastasis in Ras-activated prostate cancer.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/25436980","citation_count":83,"is_preprint":false},{"pmid":"32066947","id":"PMC_32066947","title":"HIV-1-induced cytokines deplete homeostatic innate lymphoid cells and expand TCF7-dependent memory NK cells.","date":"2020","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32066947","citation_count":76,"is_preprint":false},{"pmid":"33690816","id":"PMC_33690816","title":"Regnase-1 suppresses TCF-1+ precursor exhausted T-cell formation to limit CAR-T-cell responses against ALL.","date":"2021","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/33690816","citation_count":74,"is_preprint":false},{"pmid":"33351785","id":"PMC_33351785","title":"TCF-1 regulates HIV-specific CD8+ T cell expansion capacity.","date":"2021","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/33351785","citation_count":73,"is_preprint":false},{"pmid":"26193896","id":"PMC_26193896","title":"Elevated Hepatic miR-22-3p Expression Impairs Gluconeogenesis by Silencing the Wnt-Responsive Transcription Factor Tcf7.","date":"2015","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/26193896","citation_count":70,"is_preprint":false},{"pmid":"35637103","id":"PMC_35637103","title":"BCL6-dependent TCF-1+ progenitor cells maintain effector and helper CD4+ T cell responses to persistent antigen.","date":"2022","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/35637103","citation_count":68,"is_preprint":false},{"pmid":"30111633","id":"PMC_30111633","title":"Human Lymph Nodes Maintain TCF-1hi Memory T Cells with High Functional Potential and Clonal Diversity throughout Life.","date":"2018","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/30111633","citation_count":68,"is_preprint":false},{"pmid":"10549625","id":"PMC_10549625","title":"Clonal acquisition of the Ly49A NK cell receptor is dependent on the trans-acting factor TCF-1.","date":"1999","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/10549625","citation_count":68,"is_preprint":false},{"pmid":"22535304","id":"PMC_22535304","title":"β-catenin/TCF-1 pathway in T cell development and differentiation.","date":"2012","source":"Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/22535304","citation_count":67,"is_preprint":false},{"pmid":"35980386","id":"PMC_35980386","title":"TGF-β regulates the stem-like state of PD-1+ TCF-1+ virus-specific CD8 T cells during chronic infection.","date":"2022","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35980386","citation_count":66,"is_preprint":false},{"pmid":"34385712","id":"PMC_34385712","title":"TCF-1 controls Treg cell functions that regulate inflammation, CD8+ T cell cytotoxicity and severity of colon cancer.","date":"2021","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34385712","citation_count":65,"is_preprint":false},{"pmid":"10221643","id":"PMC_10221643","title":"Tcf-1-mediated transcription in T lymphocytes: differential role for glycogen synthase kinase-3 in fibroblasts and T cells.","date":"1999","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/10221643","citation_count":65,"is_preprint":false},{"pmid":"35487986","id":"PMC_35487986","title":"TCF-1: a maverick in T cell development and function.","date":"2022","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35487986","citation_count":64,"is_preprint":false},{"pmid":"24551047","id":"PMC_24551047","title":"Multiple tumor suppressor microRNAs regulate telomerase and TCF7, an important transcriptional regulator of the Wnt pathway.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24551047","citation_count":62,"is_preprint":false},{"pmid":"25869100","id":"PMC_25869100","title":"Inhibition of β-catenin signaling suppresses pancreatic tumor growth by disrupting nuclear β-catenin/TCF-1 complex: critical role of STAT-3.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/25869100","citation_count":59,"is_preprint":false},{"pmid":"32579593","id":"PMC_32579593","title":"Rapid in vitro generation of bona fide exhausted CD8+ T cells is accompanied by Tcf7 promotor methylation.","date":"2020","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/32579593","citation_count":58,"is_preprint":false},{"pmid":"37708030","id":"PMC_37708030","title":"STING signaling promotes NK cell antitumor immunity and maintains a reservoir of TCF-1+ NK cells.","date":"2023","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/37708030","citation_count":56,"is_preprint":false},{"pmid":"12731066","id":"PMC_12731066","title":"Redundant functions of TCF-1 and LEF-1 during T and NK cell development, but unique role of TCF-1 for Ly49 NK cell receptor acquisition.","date":"2003","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/12731066","citation_count":56,"is_preprint":false},{"pmid":"30420627","id":"PMC_30420627","title":"TCF-1 and HEB cooperate to establish the epigenetic and transcription profiles of CD4+CD8+ thymocytes.","date":"2018","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30420627","citation_count":55,"is_preprint":false},{"pmid":"37624910","id":"PMC_37624910","title":"Sustained CD28 costimulation is required for self-renewal and differentiation of TCF-1+ PD-1+ CD8 T cells.","date":"2023","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37624910","citation_count":54,"is_preprint":false},{"pmid":"35726060","id":"PMC_35726060","title":"TCF-1 promotes chromatin interactions across topologically associating domains in T cell progenitors.","date":"2022","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35726060","citation_count":54,"is_preprint":false},{"pmid":"15890681","id":"PMC_15890681","title":"Cooperating pre-T-cell receptor and TCF-1-dependent signals ensure thymocyte survival.","date":"2005","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/15890681","citation_count":54,"is_preprint":false},{"pmid":"27806296","id":"PMC_27806296","title":"Opposing Development of Cytotoxic and Follicular Helper CD4 T Cells Controlled by the TCF-1-Bcl6 Nexus.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/27806296","citation_count":48,"is_preprint":false},{"pmid":"7579399","id":"PMC_7579399","title":"The human TCF-1 gene encodes a nuclear DNA-binding protein uniquely expressed in normal and neoplastic T-lineage lymphocytes.","date":"1995","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/7579399","citation_count":48,"is_preprint":false},{"pmid":"31142588","id":"PMC_31142588","title":"TCF-1 limits the formation of Tc17 cells via repression of the MAF-RORγt axis.","date":"2019","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31142588","citation_count":47,"is_preprint":false},{"pmid":"1836958","id":"PMC_1836958","title":"TCF-1, a T cell-specific transcription factor of the HMG box family, interacts with sequence motifs in the TCR beta and TCR delta enhancers.","date":"1991","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/1836958","citation_count":45,"is_preprint":false},{"pmid":"12707037","id":"PMC_12707037","title":"Loss of expression of the WNT/beta-catenin-signaling pathway transcription factors lymphoid enhancer factor-1 (LEF-1) and T cell factor-1 (TCF-1) in a subset of peripheral T cell lymphomas.","date":"2003","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/12707037","citation_count":45,"is_preprint":false},{"pmid":"21935461","id":"PMC_21935461","title":"Critical role of TCF-1 in repression of the IL-17 gene.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21935461","citation_count":44,"is_preprint":false},{"pmid":"12951064","id":"PMC_12951064","title":"Beta-catenin/Tcf-1-mediated transactivation of cyclin D1 promoter is negatively regulated by thyroid hormone.","date":"2003","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/12951064","citation_count":43,"is_preprint":false},{"pmid":"36809763","id":"PMC_36809763","title":"The alarmin interleukin-33 promotes the expansion and preserves the stemness of Tcf-1+ CD8+ T cells in chronic viral infection.","date":"2023","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/36809763","citation_count":42,"is_preprint":false},{"pmid":"19749792","id":"PMC_19749792","title":"A Wnt kinase network alters nuclear localization of TCF-1 in colon cancer.","date":"2009","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/19749792","citation_count":40,"is_preprint":false},{"pmid":"24994854","id":"PMC_24994854","title":"TCF-1-mediated Wnt signaling regulates Paneth cell innate immune defense effectors HD-5 and -6: implications for Crohn's disease.","date":"2014","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/24994854","citation_count":40,"is_preprint":false},{"pmid":"35594339","id":"PMC_35594339","title":"Single-cell deletion analyses show control of pro-T cell developmental speed and pathways by Tcf7, Spi1, Gata3, Bcl11a, Erg, and Bcl11b.","date":"2022","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35594339","citation_count":39,"is_preprint":false},{"pmid":"35428876","id":"PMC_35428876","title":"Wnt-TCF7-SOX9 axis promotes cholangiocarcinoma proliferation and pemigatinib resistance in a FGF7-FGFR2 autocrine pathway.","date":"2022","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/35428876","citation_count":38,"is_preprint":false},{"pmid":"27683056","id":"PMC_27683056","title":"Upregulation of miR-192 inhibits cell growth and invasion and induces cell apoptosis by targeting TCF7 in human osteosarcoma.","date":"2016","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27683056","citation_count":38,"is_preprint":false},{"pmid":"18045485","id":"PMC_18045485","title":"The candidate genes TAF5L, TCF7, PDCD1, IL6 and ICAM1 cannot be excluded from having effects in type 1 diabetes.","date":"2007","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18045485","citation_count":37,"is_preprint":false},{"pmid":"1618927","id":"PMC_1618927","title":"Identification of a core motif that is recognized by three members of the HMG class of transcriptional regulators: IRE-ABP, SRY, and TCF-1 alpha.","date":"1992","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1618927","citation_count":37,"is_preprint":false},{"pmid":"26714756","id":"PMC_26714756","title":"Identification of a novel mechanism of action of fingolimod (FTY720) on human effector T cell function through TCF-1 upregulation.","date":"2015","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/26714756","citation_count":37,"is_preprint":false},{"pmid":"12765974","id":"PMC_12765974","title":"A polymorphism in the TCF7 gene, C883A, is associated with type 1 diabetes.","date":"2003","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/12765974","citation_count":36,"is_preprint":false},{"pmid":"36565920","id":"PMC_36565920","title":"Pancreatic stellate cells exploit Wnt/β-catenin/TCF7-mediated glutamine metabolism to promote pancreatic cancer cells growth.","date":"2022","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/36565920","citation_count":35,"is_preprint":false},{"pmid":"26079538","id":"PMC_26079538","title":"AF1q is a novel TCF7 co-factor which activates CD44 and promotes breast cancer metastasis.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26079538","citation_count":35,"is_preprint":false},{"pmid":"32265924","id":"PMC_32265924","title":"A Shared Regulatory Element Controls the Initiation of Tcf7 Expression During Early T Cell and Innate Lymphoid Cell Developments.","date":"2020","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32265924","citation_count":33,"is_preprint":false},{"pmid":"12226748","id":"PMC_12226748","title":"Inactivation of Apc perturbs mammary development, but only directly results in acanthoma in the context of Tcf-1 deficiency.","date":"2002","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/12226748","citation_count":33,"is_preprint":false},{"pmid":"30778164","id":"PMC_30778164","title":"Opposing roles of TCF7/LEF1 and TCF7L2 in cyclin D2 and Bmp4 expression and cardiomyocyte cell cycle control during late heart development.","date":"2019","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/30778164","citation_count":30,"is_preprint":false},{"pmid":"30528236","id":"PMC_30528236","title":"Long non-coding RNA TCF7 contributes to the growth and migration of airway smooth muscle cells in asthma through targeting TIMMDC1/Akt axis.","date":"2018","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/30528236","citation_count":29,"is_preprint":false},{"pmid":"19956102","id":"PMC_19956102","title":"Evidence for association of the TCF7 locus with type I diabetes.","date":"2009","source":"Genes and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/19956102","citation_count":29,"is_preprint":false},{"pmid":"27766570","id":"PMC_27766570","title":"Long noncoding RNA TCF7 promotes invasiveness and self-renewal of human non-small cell lung cancer cells.","date":"2016","source":"Human cell","url":"https://pubmed.ncbi.nlm.nih.gov/27766570","citation_count":29,"is_preprint":false},{"pmid":"15649465","id":"PMC_15649465","title":"lin-17/Frizzled and lin-18 regulate POP-1/TCF-1 localization and cell type specification during C. elegans vulval development.","date":"2005","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/15649465","citation_count":29,"is_preprint":false},{"pmid":"34047386","id":"PMC_34047386","title":"TCF-1 maintains CD8+ T cell stemness in tumor microenvironment.","date":"2021","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/34047386","citation_count":28,"is_preprint":false},{"pmid":"38101610","id":"PMC_38101610","title":"Dihydroartemisinin inhibits the development of colorectal cancer by GSK-3β/TCF7/MMP9 pathway and synergies with capecitabine.","date":"2023","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/38101610","citation_count":28,"is_preprint":false},{"pmid":"34309413","id":"PMC_34309413","title":"Saikosaponin-d Alleviates Renal Inflammation and Cell Apoptosis in a Mouse Model of Sepsis via TCF7/FOSL1/Matrix Metalloproteinase 9 Inhibition.","date":"2021","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/34309413","citation_count":28,"is_preprint":false},{"pmid":"15765502","id":"PMC_15765502","title":"Expression pattern of zebrafish tcf7 suggests unexplored domains of Wnt/beta-catenin activity.","date":"2005","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/15765502","citation_count":28,"is_preprint":false},{"pmid":"20980261","id":"PMC_20980261","title":"Inhibition of suppressive T cell factor 1 (TCF-1) isoforms in naive CD4+ T cells is mediated by IL-4/STAT6 signaling.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20980261","citation_count":28,"is_preprint":false},{"pmid":"9259402","id":"PMC_9259402","title":"Ectopic activation of lymphoid high mobility group-box transcription factor TCF-1 and overexpression in colorectal cancer cells.","date":"1997","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/9259402","citation_count":28,"is_preprint":false},{"pmid":"30563094","id":"PMC_30563094","title":"The Disruption of the β-Catenin/TCF-1/STAT3 Signaling Axis by 4-Acetylantroquinonol B Inhibits the Tumorigenesis and Cancer Stem-Cell-Like Properties of Glioblastoma Cells, In Vitro and In Vivo.","date":"2018","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/30563094","citation_count":28,"is_preprint":false},{"pmid":"20890621","id":"PMC_20890621","title":"Regulation of Tcf7 by Runx2 in chondrocyte maturation and proliferation.","date":"2010","source":"Journal of bone and mineral metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/20890621","citation_count":27,"is_preprint":false},{"pmid":"22466651","id":"PMC_22466651","title":"Aberrant nuclear localization of EBP50 promotes colorectal carcinogenesis in xenotransplanted mice by modulating TCF-1 and β-catenin interactions.","date":"2012","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/22466651","citation_count":27,"is_preprint":false},{"pmid":"30225781","id":"PMC_30225781","title":"Down-regulation of lncTCF7 inhibits cell migration and invasion in colorectal cancer via inhibiting TCF7 expression.","date":"2018","source":"Human cell","url":"https://pubmed.ncbi.nlm.nih.gov/30225781","citation_count":27,"is_preprint":false},{"pmid":"24858819","id":"PMC_24858819","title":"Wnt signaling transcription factors TCF-1 and LEF-1 are upregulated in malignant astrocytic brain tumors.","date":"2014","source":"Histology and histopathology","url":"https://pubmed.ncbi.nlm.nih.gov/24858819","citation_count":27,"is_preprint":false},{"pmid":"1577072","id":"PMC_1577072","title":"A common ancestor of the mammalian transcription factors TCF-1 and TCF-1 alpha/LEF-1 expressed in chicken T cells.","date":"1992","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/1577072","citation_count":27,"is_preprint":false},{"pmid":"36681742","id":"PMC_36681742","title":"BET inhibitors rescue anti-PD1 resistance by enhancing TCF7 accessibility in leukemia-derived terminally exhausted CD8+ T cells.","date":"2023","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/36681742","citation_count":26,"is_preprint":false},{"pmid":"28220803","id":"PMC_28220803","title":"TCF7 is suppressed by the androgen receptor via microRNA-1-mediated downregulation and is involved in the development of resistance to androgen deprivation in prostate cancer.","date":"2017","source":"Prostate cancer and prostatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/28220803","citation_count":26,"is_preprint":false},{"pmid":"32868912","id":"PMC_32868912","title":"Exploring the stage-specific roles of Tcf-1 in T cell development and malignancy at single-cell resolution.","date":"2020","source":"Cellular & molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32868912","citation_count":25,"is_preprint":false},{"pmid":"28198400","id":"PMC_28198400","title":"Ubiquitin C-terminal hydrolase37 regulates Tcf7 DNA binding for the activation of Wnt signalling.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28198400","citation_count":24,"is_preprint":false},{"pmid":"28485543","id":"PMC_28485543","title":"Andrographolide Induces Cell Cycle Arrest and Apoptosis of Chondrosarcoma by Targeting TCF-1/SOX9 Axis.","date":"2017","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28485543","citation_count":24,"is_preprint":false},{"pmid":"12711535","id":"PMC_12711535","title":"Tcf-1 expression during Xenopus development.","date":"2003","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/12711535","citation_count":23,"is_preprint":false},{"pmid":"33705946","id":"PMC_33705946","title":"Soybean-derived gma-miR159a alleviates colon tumorigenesis by suppressing TCF7/MYC in mice.","date":"2021","source":"The Journal of nutritional biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33705946","citation_count":22,"is_preprint":false},{"pmid":"29358218","id":"PMC_29358218","title":"T Cell Factor 7 (TCF7)/TCF1 Feedback Controls Osteocalcin Signaling in Brown Adipocytes Independent of the Wnt/β-Catenin Pathway.","date":"2018","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/29358218","citation_count":22,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":46953,"output_tokens":9771,"usd":0.143712},"stage2":{"model":"claude-opus-4-6","input_tokens":13786,"output_tokens":4236,"usd":0.262245},"total_usd":0.405957,"stage1_batch_id":"msgbatch_01RPbVc9PDH9zQmYK5Hs6srm","stage2_batch_id":"msgbatch_01JVbVLzeKN2yVrsGp3zC8aM","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1991,\n      \"finding\": \"TCF-1 was identified as a T cell-specific transcription factor containing a single DNA-binding HMG box that binds to a sequence-specific motif (AACAAAG/TTCAAAG) in the CD3-epsilon and TCR alpha enhancers, and upon cotransfection into non-T cells can transactivate through its cognate motif.\",\n      \"method\": \"Protein purification, gel retardation, methylation interference, cotransfection reporter assays, cDNA cloning\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — original identification with multiple orthogonal biochemical and functional assays, replicated across human and murine TCF-1\",\n      \"pmids\": [\"1989880\", \"1827138\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"The HMG boxes of TCF-1 and SRY recognize the heptamer motif A/T A/T C A A A G predominantly through nucleotide contacts in the minor groove of the DNA double helix, without major groove guanine contacts.\",\n      \"method\": \"Methylation interference footprinting, DEPC carbethoxylation interference, T→C and A→I substitution assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal biochemical footprinting methods defining the binding mechanism\",\n      \"pmids\": [\"1639073\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"TCF-1 binds specifically to functional T cell-specific elements in the TCR beta (T beta 5) and TCR delta (T delta 7) enhancers, in addition to the CD3-epsilon and TCR alpha enhancers, defining a consensus binding motif A/T A/T C A A/G A G.\",\n      \"method\": \"Gel retardation analysis, sequence comparison\",\n      \"journal\": \"International immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct binding assays with purified recombinant protein across multiple enhancers\",\n      \"pmids\": [\"1836958\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"TCF-1 (hLEF/TCF-1 alpha) contains a context-dependent transcriptional activation domain (amino acids 80–256, bipartite, proline-rich with tyrosine/serine motifs) separate from the HMG box that activates the TCR alpha enhancer in a T cell- and context-specific manner dependent on the neighboring TCF-2 binding site.\",\n      \"method\": \"GAL4 fusion transactivation assays, deletion and clustered amino acid substitution mutagenesis, reporter gene assays in T cell lines\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution with mutagenesis mapping the activation domain, multiple controls\",\n      \"pmids\": [\"8253387\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"TCF-1 is generated from two promoters and extensive alternative splicing producing isoforms of 25–55 kDa; inclusion of an extended N-terminal 116 amino acids (from an upstream promoter) confers similarity to LEF-1 and enables transactivation through the TCR alpha enhancer, establishing functional differences between isoforms.\",\n      \"method\": \"Western blotting, cDNA cloning, RACE, reporter transactivation assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct molecular characterization with functional isoform comparison\",\n      \"pmids\": [\"8622675\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"TCF-1 interacts with beta-catenin to become transcriptionally active in T cells, but unlike fibroblasts, inhibition of GSK-3beta (by lithium or PHA) is insufficient to activate TCF-dependent transcription in T lymphocytes, indicating a cell-type-specific difference in Wnt pathway regulation.\",\n      \"method\": \"Tcf reporter gene assays, dominant-negative GSK-3beta expression, lithium treatment in T cell lines vs. fibroblasts\",\n      \"journal\": \"International immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional reporter assays with multiple perturbations comparing cell types\",\n      \"pmids\": [\"10221643\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"TCF-1 binds to two sites in the Ly49A NK cell receptor promoter and regulates its transcriptional activity; TCF-1 dosage determines the size of the Ly49A NK cell subset in vivo, establishing TCF-1 as a trans-acting regulator of clonal NK receptor acquisition.\",\n      \"method\": \"Promoter binding assays, in vivo TCF-1 dosage analysis in knockout mice\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct promoter binding combined with in vivo genetic dosage experiment\",\n      \"pmids\": [\"10549625\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"The beta-catenin-binding domain of TCF-1 is required for survival of CD4+CD8+ double-positive thymocytes; loss of this domain leads to accelerated apoptosis correlated with decreased Bcl-xL expression, and this survival defect is rescued by a Bcl-2 transgene.\",\n      \"method\": \"Domain deletion knock-in mice, Bcl-2 transgene rescue, apoptosis assays, Bcl-xL expression analysis\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — genetic rescue experiment with domain-specific allele and mechanistic link to Bcl-xL/Bcl-2\",\n      \"pmids\": [\"11477404\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Wnt1 and Wnt4 signals activate TCF-1-dependent transcription in thymocytes (demonstrated by Tcf-LacZ reporter mice); retroviral expression of soluble Wnt receptor mutants blocking Wnt signaling inhibits thymocyte development, and the beta-catenin–TCF-1 interaction is required for full thymocyte development.\",\n      \"method\": \"Tcf-LacZ reporter mice, retroviral Wnt receptor blockade, in vitro thymocyte culture\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo reporter and loss-of-function with Wnt pathway perturbation\",\n      \"pmids\": [\"11265645\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"TCF-1 ensures survival of pre-TCR+ thymocytes through its N-terminal beta-catenin-binding domain; pre-TCR signaling induces TCF-1 expression and activates a Wnt/catenin/TCF reporter, while Wnt signals provide beta-catenin as coactivator, indicating cooperative integration of pre-TCR and Wnt signals for thymocyte survival.\",\n      \"method\": \"Domain-specific TCF-1 allele knock-in mice, Wnt/TCF reporter transgene, pre-TCR signaling analysis\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with domain-specific allele and in vivo reporter\",\n      \"pmids\": [\"15890681\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TCF-1 is required for the establishment of CD8+ memory precursor T cells; its function in generating central memory CD8+ T cells depends on the catenin-binding domain and requires beta-catenin and gamma-catenin as coactivators.\",\n      \"method\": \"Tcf-1 knockout mice, LCMV infection model, secondary challenge, catenin-binding domain mutant analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with domain-specific analysis and clear phenotypic readout in vivo\",\n      \"pmids\": [\"20457902\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Forced expression of TCF-1 in bone marrow progenitors drives T-lineage cell development even in the absence of Notch1 signals, inducing expression of T cell genes including Gata3, Bcl11b, and TCR components; Notch signals induce TCF-1 which in turn imprints T cell fate.\",\n      \"method\": \"Retroviral forced expression in bone marrow progenitors, T cell development assays in vivo, gene expression profiling\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — gain-of-function in vivo with clear downstream gene activation and epistasis to Notch\",\n      \"pmids\": [\"21814277\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TCF-1 represses the IL-17 gene locus via epigenetic modifications (preventing histone hyperacetylation and H3K4 trimethylation at the IL-17 locus) during T cell development in the thymus; this chromatin silencing is established in thymocytes and maintained in peripheral T cells, restricting Th17 differentiation.\",\n      \"method\": \"Tcf-1 knockout mice, chromatin immunoprecipitation (histone modification), EAE model, reconstitution experiments\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP demonstrating epigenetic mechanism combined with KO and reconstitution\",\n      \"pmids\": [\"21935461\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"TCF-1 directly represses LEF-1 expression in early thymocytes; loss of TCF-1 leads to aberrant LEF-1 upregulation and T cell malignancy resembling T-ALL, and conditional inactivation of Lef1 greatly delays or prevents T cell malignancy in Tcf7-/- mice.\",\n      \"method\": \"Tcf7 knockout mice, ChIP for TCF-1 binding at Lef1 locus, conditional Lef1 knockout rescue experiments\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct binding evidence (ChIP) combined with genetic epistasis (double KO rescue)\",\n      \"pmids\": [\"23103132\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"TCF-1 functions as a self-renewal/differentiation switch in multipotential hematopoietic precursors independently of autocrine Wnt signaling; TCF-1 binds RUNX1 promoter regions and is necessary for production of short but not long RUNX1 isoforms, and the two factors coordinately regulate self-renewal genes.\",\n      \"method\": \"RNA-seq, ChIP-seq, siRNA knockdown, reporter assays in EML hematopoietic cell line\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-seq for TCF7 binding combined with KD and transcriptomic analysis\",\n      \"pmids\": [\"22412390\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"TCF-1 and LEF-1 promote the CD4+ T cell fate by directly activating the Th-POK transcription factor; TCF-1 also physically interacts with Runx3 to cooperatively silence the Cd4 gene in CD8+ T cells, establishing distinct genetic mechanisms for CD4 vs. CD8 lineage decisions.\",\n      \"method\": \"DP-specific conditional knockout, ChIP, Co-immunoprecipitation (physical interaction with Runx3), reporter assays\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct physical interaction by Co-IP, ChIP, and genetic KO with defined lineage phenotype\",\n      \"pmids\": [\"24836425\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"TCF-1 directly binds the Bcl6 promoter to promote Bcl-6 expression and the Prdm1 5' regulatory region to repress Blimp1 expression, thereby initiating TFH differentiation by acting upstream of the Bcl-6–Blimp1 axis during acute viral infection.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP) at Bcl6 and Prdm1 loci, Tcf7 knockout mice, LCMV infection\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct promoter binding by ChIP with genetic KO and clear mechanistic pathway\",\n      \"pmids\": [\"26214740\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"LEF-1 and TCF-1 promote TFH differentiation by sustaining expression of cytokine receptors IL-6Rα and gp130, enhancing ICOS expression, and promoting Bcl6 expression, functioning upstream of the Bcl-6 transcriptional repressor circuit.\",\n      \"method\": \"Selective Lef1 and Tcf7 single and double conditional knockout mice, LEF-1 forced expression, gene expression analysis\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with single and double KO combined with gain-of-function\",\n      \"pmids\": [\"26214741\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"TCF-1 is required for efficient generation of all innate lymphoid cell (ILC) subsets; upregulation of TCF-1 marks early ILC-committed progenitors (EILPs) that efficiently give rise to NK cells and all helper ILC lineages but lack T and B cell potential.\",\n      \"method\": \"Tcf7 reporter mice, conditional knockout, adoptive transfer, lineage potential assays\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with reporter-based progenitor identification and lineage tracing\",\n      \"pmids\": [\"26280998\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"TCF-1 acts as a lineage-determining transcription factor that establishes the epigenetic identity of T cells by targeting silent chromatin and generating de novo chromatin accessibility; TCF-1 expression in fibroblasts opens chromatin at T cell-restricted gene loci even at regions with repressive marks.\",\n      \"method\": \"ATAC-seq across 8 T cell developmental stages, gain-of-function in fibroblasts, TCF-1 loss-of-function, single-cell chromatin profiling\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal genomic methods with gain- and loss-of-function in non-T cell context\",\n      \"pmids\": [\"29466756\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"TCF-1 and HEB co-occupy ~7,000 genomic sites; TCF-1 displaces nucleosomes to promote chromatin accessibility, and TCF-1 inhibits Notch signaling to protect HEB from Notch-mediated proteasomal degradation, enabling cooperative regulation of the DP thymocyte transcriptional and epigenetic program.\",\n      \"method\": \"ChIP-seq, ATAC-seq, proteasome inhibition assays, Notch pathway perturbation, conditional KO\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal genomic methods with mechanistic protein stability assay\",\n      \"pmids\": [\"30420627\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TCF-1 mediates the bifurcation between terminal effector (KLRG1hi) and exhausted precursor (KLRG1lo) CD8 T cell fates during chronic infection by repressing terminal effectors, promoting Eomes over T-bet, and driving c-Myb expression to control Bcl-2 and survival; PD-1 stabilizes the TCF-1+ Tex precursor pool.\",\n      \"method\": \"scRNA-seq, lineage tracing, TCF-1 conditional KO, gene expression analysis during LCMV chronic infection\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with scRNA-seq and lineage tracing establishing mechanistic pathway\",\n      \"pmids\": [\"31606264\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TCF-1 limits Tc17 (IL-17-producing CD8+ T) cell development through sequential suppression of MAF and RORγt transcription factors in double-positive thymocytes, in parallel with TCF-1-driven modulation of chromatin state.\",\n      \"method\": \"TCF-1 conditional KO (DP stage), RNA-seq, ATAC-seq, MAF/RORγt expression analysis\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with genomic profiling defining the MAF-RORγt repression axis\",\n      \"pmids\": [\"31142588\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TCF-1 enforces ILC lineage commitment by binding pre-existing chromatin regulatory elements established in upstream lymphoid precursors in EILPs; TCF-1 is dispensable for specified EILPs but required for committed EILPs and restricts dendritic cell lineage potential.\",\n      \"method\": \"Single-cell transcriptomics, TCF-1 conditional KO, chromatin accessibility profiling (ATAC-seq), adoptive transfer lineage tracing\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — single-cell genomics combined with genetic KO and lineage tracing\",\n      \"pmids\": [\"31358996\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Tcf7 promoter DNA methylation contributes to TCF-1 downregulation in exhausted CD8+ T cells, as demonstrated using an in vitro repeated stimulation exhaustion model where exhausted CTL showed Tcf7 promoter hypermethylation correlating with reduced TCF-1 expression.\",\n      \"method\": \"In vitro exhaustion model, promoter DNA methylation analysis, transcriptomic comparison to in vivo LCMV exhaustion\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct epigenetic measurement correlating Tcf7 promoter methylation with TCF-1 loss\",\n      \"pmids\": [\"32579593\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Regnase-1 directly targets Tcf7 mRNA; its deficiency augments TCF-1 protein expression, promoting formation of TCF-1+ precursor exhausted T cells with upregulated memory and exhaustion markers, and enhancing CAR-T-cell expansion, persistence, and memory-like cell formation.\",\n      \"method\": \"Regnase-1 KO mouse model, phenotypic/transcriptional/epigenetic profiling, human CAR-T xenograft model\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct mRNA targeting with functional consequences in mouse and human models\",\n      \"pmids\": [\"33690816\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"TCF-1 primarily suppresses transcription of genes co-bound by Foxp3 in regulatory T cells; TCF-1 deficiency in Tregs promotes alternative TH17-associated signaling pathways, gut-homing properties, and impairs control of CD4+ T cell polarization and inflammation without altering the core Treg transcriptional signature.\",\n      \"method\": \"Treg-specific TCF-1 conditional KO, scRNA-seq, ChIP-seq, tumor models\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Treg-specific KO with scRNA-seq and ChIP-seq defining the co-bound Foxp3 gene repression mechanism\",\n      \"pmids\": [\"34385712\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"TCF-1 co-occupancy with the architectural protein CTCF alters topologically associating domain (TAD) structure in T cell progenitors, creating long-range chromatin interactions between previously insulated regulatory elements and target genes; this is linked to H3K27ac deposition and NIPBL recruitment at active enhancers.\",\n      \"method\": \"Hi-C, ChIP-seq, ATAC-seq, TCF-1 gain- and loss-of-function in T cell progenitors\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — 3D genome analysis by Hi-C with gain- and loss-of-function and mechanistic chromatin factor recruitment\",\n      \"pmids\": [\"35726060\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Runx2 transcriptionally activates the Tcf7 promoter in chondrocytes (0.3 kb proximal promoter region responsible for Runx2-dependent activation); dominant-negative Tcf7 in Col2a1-expressing chondrocytes causes dwarfism, retarded mineralization, and reduced chondrocyte proliferation, indicating TCF-1 is required for chondrocyte maturation and proliferation downstream of Runx2.\",\n      \"method\": \"Microarray, reporter assays with Tcf7 promoter deletion constructs, dominant-negative transgenic mice, BrdU labeling, in situ hybridization\",\n      \"journal\": \"Journal of bone and mineral metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — promoter reporter assays combined with dominant-negative transgenic phenotype\",\n      \"pmids\": [\"20890621\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"In normal colon cells, a dominant-negative TCF-1 isoform (dnTCF-1) is equally distributed between nuclear and cytoplasmic compartments, whereas in colon cancer cells TCF-1 is predominantly cytoplasmic due to active nuclear export directed by an autocrine Wnt ligand that requires CaMKII activity for secretion.\",\n      \"method\": \"Immunofluorescence, nuclear export inhibition, CaMKII inhibition, Wnt ligand blocking in colon cancer vs. normal cells\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization experiments with pharmacological dissection of the export mechanism\",\n      \"pmids\": [\"19749792\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"IL-4 signaling via STAT6 downregulates TCF-1 expression in human naive CD4+ T cells, preferentially suppressing the shorter dominant-negative TCF-1 isoforms; STAT6 directly binds the TCF-1 regulatory region as shown by EMSA and ChIP.\",\n      \"method\": \"EMSA, ChIP, STAT6 knockdown, qPCR, cytokine treatment of primary human T cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct binding evidence (EMSA, ChIP) with KD mechanistic follow-up\",\n      \"pmids\": [\"20980261\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"miR-22-3p binds to the 3' UTR of TCF7 mRNA and downregulates its expression; knockdown of TCF7 in hepatocytes upregulates gluconeogenic genes, and in vivo antagomiR-mediated silencing of miR-22-3p restores hepatic TCF7 and reduces gluconeogenesis in diabetic mice.\",\n      \"method\": \"Luciferase 3'UTR reporter assay, siRNA knockdown, antagomiR in vivo, gluconeogenic gene expression\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct 3'UTR binding validated by reporter assay with in vivo rescue\",\n      \"pmids\": [\"26193896\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"The deubiquitinase Uch37 interacts with TCF-1 (Tcf7) and its deubiquitinase activity is required for Tcf7 association with target gene promoters (chromatin occupancy), without affecting TCF-1 protein stability, thereby activating Wnt/beta-catenin target gene expression in Xenopus embryos and human liver cancer cells.\",\n      \"method\": \"Co-immunoprecipitation, ChIP in Xenopus embryo and HCC cells, Uch37 knockdown/overexpression, deubiquitinase activity mutants\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP with functional ChIP demonstrating chromatin occupancy mechanism\",\n      \"pmids\": [\"28198400\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"TCF7 is a direct target of miR-34a; ectopic miR-34a inhibits bone metastasis in Ras-activated prostate cancer and reduces TCF7-driven WNT signaling; TCF7 itself has oncogenic properties in prostate cancer cells promoting androgen-independent proliferation.\",\n      \"method\": \"miR-34a ectopic expression, xenograft model, WNT gene signature analysis, TCF7 expression correlation with miR-34a\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — functional cancer model with indirect evidence of TCF7 as miR-34a target; no direct 3'UTR validation described\",\n      \"pmids\": [\"25436980\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"AF1q specifically binds to TCF7 protein in the Wnt signaling pathway and results in transcriptional activation of CD44 and downstream TCF7/LEF1 targets; AF1q promotes breast cancer proliferation, migration, mammosphere formation, and metastasis through the AF1q/TCF7/CD44 axis.\",\n      \"method\": \"Co-immunoprecipitation (AF1q–TCF7 interaction), reporter/gene expression assays, xenograft models\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single Co-IP identifying novel binding partner with downstream functional assays\",\n      \"pmids\": [\"26079538\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"TCF-1 functions in brown adipocytes to modulate Gprc6a and Ucp1 promoter activation independent of beta-catenin, requiring PRDM16 and the histone demethylase LSD1 as coactivators, as part of an osteocalcin-GPRC6A-TCF7 feedback axis in thermogenesis.\",\n      \"method\": \"Overexpression and knockdown of Tcf7, promoter reporter assays, co-factor interaction studies in brown adipocytes\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — promoter assays with beta-catenin independence shown, but single study with limited mechanistic detail on PRDM16/LSD1 interaction\",\n      \"pmids\": [\"29358218\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"TCF-1-mediated Wnt signaling activates alpha-defensin HD-5 and HD-6 transcription in Paneth cells via three distinct TCF binding sites in the defensin promoters; binding of TCF-1 to these motifs was confirmed by EMSA, and TCF-1 cooperates with beta-catenin to activate transcription.\",\n      \"method\": \"Reporter gene assays, EMSA, promoter binding analysis, Tcf-1 knockout mice (cryptdin expression)\",\n      \"journal\": \"American journal of physiology. Gastrointestinal and liver physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — EMSA and reporter assay with in vivo knockout validation\",\n      \"pmids\": [\"24994854\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"A 1 kb regulatory element containing a Notch binding site is crucial for initiation of Tcf7 expression in T cells and innate lymphoid cells, but different transcriptional controllers use this same element in T cells vs. ILCs; Notch binding is required for Tcf7 initiation in T cells but not in ILCs.\",\n      \"method\": \"Regulatory element deletion analysis, reporter mice, Notch binding site mutation, Tcf7 expression in multiple lineages\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — regulatory element deletion with lineage-specific mechanistic distinction\",\n      \"pmids\": [\"32265924\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Single-cell CRISPR disruption of Tcf7 in early T cell progenitors reveals a kinetic tug-of-war with progenitor factors Spi1/Bcl11a, where Tcf7 functions before T lineage commitment to regulate developmental speed and cell fate choices at the DN1 stage.\",\n      \"method\": \"Single-cell CRISPR disruption, scRNA-seq, synchronized in vitro differentiation\",\n      \"journal\": \"Science immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — single-cell CRISPR KO with transcriptomic readout defining epistatic relationships\",\n      \"pmids\": [\"35594339\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Tcf7hi effector-phase CD8+ T cells show no evidence of prior cytolytic differentiation and quantitatively give rise to central memory T cells based on lineage tracing; mechanistically, Tcf1 counteracts Tcf7hi cell differentiation and sustains expression of conserved adult stem-cell genes critical for CD8 T cell stemness.\",\n      \"method\": \"Lineage tracing, scRNA-seq, Tcf7 conditional KO, gene expression analysis during acute infection\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — lineage tracing combined with KO defining mechanistic role in stemness maintenance\",\n      \"pmids\": [\"33128876\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CRISPR-Cas9 editing of TCF-1 in human primary T cells directly reduces expansion capacity, demonstrating a cell-intrinsic role for TCF-1 in regulating the secondary expansion (stem-like memory) property of HIV-specific CD8+ T cells.\",\n      \"method\": \"CRISPR-Cas9 editing of TCF-1 in human primary T cells, expansion assays\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct CRISPR KO in primary human cells with functional expansion readout\",\n      \"pmids\": [\"33351785\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"TGF-β signaling maintains the stem-like state and quiescence of PD-1+ TCF-1+ CD8 T cells during chronic LCMV infection; TGF-β regulates the unique transcriptional program of these cells including upregulation of inhibitory receptors specifically expressed on them, and promotes terminal differentiation of exhausted CD8 T cells by suppressing the effector program.\",\n      \"method\": \"TGF-β receptor conditional KO in virus-specific CD8 T cells, transcriptomic analysis, LCMV chronic infection model\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — cell-specific KO with transcriptomic definition of the TCF-1+ stem-like subset regulation\",\n      \"pmids\": [\"35980386\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"IL-10R–STAT3 signaling maintains the PD-1int TCF-1+ CD8+ T cell population; inhibition of IL-10R signaling alters chromatin accessibility and disrupts NFAT/AP-1 cooperativity, promoting an NFAT-associated exhaustion program and accumulation of PD-1hi cells.\",\n      \"method\": \"Il10rb/Stat3 conditional KO, scRNA-seq, ATAC-seq, CLL mouse model\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — cell-specific KO with chromatin accessibility and transcriptomic analysis\",\n      \"pmids\": [\"34879221\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"IL-33–ST2 signaling is pivotal for expansion and maintenance of stem-like TCF-1+ CD8+ T cells during chronic viral infection; ST2-deficient CD8+ T cells show biased terminal differentiation and premature loss of Tcf-1, effects rescued by blockade of type I interferon; IL-33 broadly augments chromatin accessibility in TCF-1+ stem-like cells.\",\n      \"method\": \"ST2-KO mice, chronic LCMV infection, ATAC-seq, type I IFN blockade rescue, lineage tracing\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with chromatin profiling and cytokine pathway rescue\",\n      \"pmids\": [\"36809763\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"The androgen receptor suppresses TCF7 expression partly through induction of miR-1 which targets TCF7 mRNA; TCF7 overexpression or disruption of miR-1 function promotes androgen-independent proliferation in prostate cancer, demonstrating TCF7 as an oncogenic factor controlled by the AR-miR-1 axis.\",\n      \"method\": \"miR-1 overexpression, TCF7 overexpression/knockdown, xenograft model, clinical dataset analysis\",\n      \"journal\": \"Prostate cancer and prostatic diseases\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — functional cancer model with indirect miRNA-TCF7 relationship; miR-1 3'UTR validation not explicitly detailed in abstract\",\n      \"pmids\": [\"28220803\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TCF-1 (encoded by TCF7) is a T cell-specific HMG-box transcription factor that binds DNA primarily through minor groove contacts at AACAAAG motifs, activates or represses target genes through beta-catenin-dependent and -independent mechanisms, establishes chromatin accessibility and epigenetic identity at T cell lineage loci (including by displacing nucleosomes and organizing 3D genome architecture via CTCF co-occupancy), acts as a lineage-determining factor for T cells and ILCs by enforcing lineage-specific gene programs while suppressing alternative fates (repressing LEF-1, IL-17, MAF/RORγt, and alternative lineage regulators), and sustains stem-like CD8+ T cell properties in chronic infection and tumors by maintaining TCF-1+ precursor exhausted T cells through Wnt/beta-catenin signaling, epigenetic maintenance, and responses to cytokine cues including IL-33, TGF-β, and IL-10R–STAT3 pathways.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"TCF-1 (encoded by TCF7) is a sequence-specific HMG-box transcription factor that serves as a master regulator of T cell and innate lymphoid cell (ILC) lineage identity, chromatin architecture, and stem-like T cell maintenance. TCF-1 binds the minor groove of DNA at AACAAAG motifs in T cell receptor and other lymphoid gene enhancers, activating or repressing transcription through both β-catenin-dependent and -independent mechanisms; its N-terminal β-catenin-binding domain is required for thymocyte survival via Bcl-xL induction and for CD8+ memory T cell generation [PMID:1989880, PMID:11477404, PMID:20457902]. As a pioneer-like factor, TCF-1 displaces nucleosomes to establish de novo chromatin accessibility at T cell-restricted loci, co-occupies genomic sites with CTCF to reorganize three-dimensional genome topology, and epigenetically silences alternative lineage programs including IL-17/RORγt, MAF, and LEF-1, whose aberrant upregulation in TCF-1-deficient mice causes T-ALL [PMID:29466756, PMID:35726060, PMID:23103132, PMID:31142588]. TCF-1 also sustains stem-like TCF-1⁺ precursor exhausted CD8⁺ T cells during chronic infection and cancer—maintained by TGF-β, IL-33–ST2, and IL-10R–STAT3 signals—and initiates T follicular helper differentiation by directly activating Bcl6 and repressing Blimp1 [PMID:31606264, PMID:36809763, PMID:26214740].\",\n  \"teleology\": [\n    {\n      \"year\": 1991,\n      \"claim\": \"The identity of the T cell-specific factor recognizing TCR/CD3 enhancers was unknown; cloning and biochemical characterization of TCF-1 revealed a single HMG-box protein that binds AACAAAG motifs and transactivates in T cells, establishing TCF-1 as the founding TCR enhancer-binding factor.\",\n      \"evidence\": \"Protein purification, gel retardation, methylation interference, cotransfection reporter assays, cDNA cloning in human and murine T cells\",\n      \"pmids\": [\"1989880\", \"1827138\", \"1836958\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Three-dimensional structure of TCF-1 HMG box on DNA not yet determined\", \"Mechanism of T cell-specific expression not defined\"]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"How TCF-1/HMG-box proteins contact DNA was unclear; footprinting showed recognition occurs predominantly through minor groove contacts without major groove guanine interactions, distinguishing this from classical transcription factor binding modes.\",\n      \"evidence\": \"Methylation interference, DEPC carbethoxylation, nucleotide substitution assays\",\n      \"pmids\": [\"1639073\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for sequence selectivity via minor groove not resolved at atomic level\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Whether TCF-1 has an autonomous activation domain was unresolved; mapping identified a bipartite, context-dependent activation domain (aa 80–256) that functions only with cooperating elements, and alternative promoter usage was shown to generate functionally distinct long and short isoforms.\",\n      \"evidence\": \"GAL4 fusion mutagenesis, reporter assays in T cell lines, cDNA cloning and RACE\",\n      \"pmids\": [\"8253387\", \"8622675\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cofactors mediating context-dependent activation not identified\", \"Relative isoform abundance across developmental stages incompletely mapped\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"The functional requirement for β-catenin interaction was unknown; domain-specific knock-in mice demonstrated that the β-catenin-binding domain is essential for DP thymocyte survival via Bcl-xL, and that Wnt1/Wnt4 ligands activate TCF-1-dependent transcription in thymocytes.\",\n      \"evidence\": \"β-catenin-binding domain deletion knock-in mice, Bcl-2 transgene rescue, Tcf-LacZ reporter mice, retroviral Wnt blockade\",\n      \"pmids\": [\"11477404\", \"11265645\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether γ-catenin compensates in vivo not tested\", \"Upstream Wnt ligand source in thymic microenvironment not defined\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Whether TCF-1 functions in CD8+ memory formation was untested; knockout and domain-mutant studies showed TCF-1's β-catenin-binding domain is required for central memory CD8+ T cell generation, with β-catenin and γ-catenin as coactivators.\",\n      \"evidence\": \"Tcf-1 KO mice, LCMV infection, secondary challenge, catenin-binding domain mutant analysis\",\n      \"pmids\": [\"20457902\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct TCF-1 target genes in memory precursors not identified\", \"Relative contribution of β- vs. γ-catenin not dissected\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Whether TCF-1 is sufficient to initiate T cell fate was unknown; forced TCF-1 expression in bone marrow progenitors drove T lineage gene programs (Gata3, Bcl11b) even without Notch, placing TCF-1 downstream of Notch as a T cell fate-determining factor, while also revealing epigenetic repression of IL-17 loci.\",\n      \"evidence\": \"Retroviral gain-of-function in BM progenitors, in vivo development assays, ChIP for histone modifications at IL-17 locus in KO mice\",\n      \"pmids\": [\"21814277\", \"21935461\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TCF-1 alone is sufficient without any other Notch-induced factors unclear\", \"Mechanism of epigenetic silencing (writer/eraser recruitment) not identified\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"How TCF-1 loss causes T-ALL was unexplained; ChIP and genetic epistasis demonstrated TCF-1 directly represses LEF-1 transcription, and aberrant LEF-1 upregulation drives T cell malignancy, which is rescued by conditional Lef1 deletion.\",\n      \"evidence\": \"ChIP at Lef1 locus, Tcf7 KO mice developing T-ALL, conditional Lef1 KO rescue\",\n      \"pmids\": [\"23103132\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether LEF-1 is the sole oncogenic driver or cooperates with other derepressed genes not fully resolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"How TCF-1 controls CD4/CD8 lineage choice was mechanistically unclear; TCF-1 was shown to directly activate ThPOK for CD4 fate and physically interact with Runx3 to silence Cd4 in CD8 cells, revealing dual mechanisms for lineage bifurcation.\",\n      \"evidence\": \"DP-specific conditional KO, ChIP, Co-IP for TCF-1–Runx3 interaction, reporter assays\",\n      \"pmids\": [\"24836425\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the TCF-1–Runx3 interaction is direct or bridged by other factors not resolved by Co-IP alone\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"TCF-1's role in T follicular helper differentiation was unknown; ChIP demonstrated direct TCF-1 binding at Bcl6 and Prdm1 loci to activate Bcl-6 and repress Blimp1, while also sustaining IL-6Rα/gp130 and ICOS expression, positioning TCF-1 as the initiator of the TFH program. Concurrently, TCF-1 was established as essential for all ILC subsets by marking early ILC-committed progenitors.\",\n      \"evidence\": \"ChIP at Bcl6/Prdm1 loci, Tcf7 KO with LCMV infection, Tcf7 reporter mice for ILC progenitor identification, conditional KO lineage assays\",\n      \"pmids\": [\"26214740\", \"26214741\", \"26280998\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TCF-1 directly or indirectly regulates Bcl6 in TFH vs. GC-B cells not distinguished\", \"Cofactors at ILC progenitor stage not defined\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Whether TCF-1 functions as a pioneer factor to establish chromatin accessibility was untested; ATAC-seq across developmental stages and gain-of-function in fibroblasts showed TCF-1 opens chromatin de novo at T cell-restricted loci, displaces nucleosomes, and protects HEB from Notch-mediated degradation at co-occupied sites.\",\n      \"evidence\": \"ATAC-seq, ChIP-seq, TCF-1 ectopic expression in fibroblasts, proteasome inhibition assays, conditional KO\",\n      \"pmids\": [\"29466756\", \"30420627\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TCF-1 directly contacts and displaces histones or requires remodeling machinery not determined\", \"Genome-wide nucleosome displacement kinetics not measured\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"How TCF-1 governs the bifurcation between terminal effector and exhausted precursor CD8+ T cells was unclear; scRNA-seq and lineage tracing revealed TCF-1 represses terminal effector fate, promotes Eomes and c-Myb for survival, and limits Tc17 development by sequentially suppressing MAF and RORγt. In ILCs, TCF-1 binds pre-existing regulatory elements to enforce lineage commitment while restricting DC potential.\",\n      \"evidence\": \"scRNA-seq, lineage tracing, TCF-1 conditional KO in chronic LCMV and DP thymocytes, ATAC-seq, adoptive transfer\",\n      \"pmids\": [\"31606264\", \"31142588\", \"31358996\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct TCF-1 target genes maintaining the exhausted precursor state not comprehensively defined\", \"Whether MAF/RORγt suppression is via direct promoter binding or indirect chromatin remodeling not fully resolved\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"The cytokine signals and chromatin mechanisms sustaining TCF-1+ stem-like CD8+ T cells were incompletely understood; multiple studies revealed IL-10R–STAT3 maintains the TCF-1+ pool by preserving NFAT/AP-1 cooperativity, Regnase-1 post-transcriptionally limits Tcf7 mRNA abundance, and TCF-1 suppresses alternative TH17 programs at Foxp3 co-bound genes in Tregs.\",\n      \"evidence\": \"Il10rb/Stat3 conditional KO with ATAC-seq, Regnase-1 KO with CAR-T functional assays, Treg-specific TCF-1 KO with scRNA-seq and ChIP-seq\",\n      \"pmids\": [\"34879221\", \"33690816\", \"34385712\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether IL-10R–STAT3 acts directly on Tcf7 transcription or indirectly through chromatin remodeling not resolved\", \"Regnase-1 binding site on Tcf7 mRNA not mapped precisely\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"How TCF-1 reorganizes 3D genome architecture was unknown; Hi-C revealed TCF-1 co-occupancy with CTCF alters TAD boundaries, creating long-range enhancer-gene contacts with NIPBL recruitment and H3K27ac deposition, while single-cell CRISPR showed TCF-1 acts before T lineage commitment in a kinetic competition with progenitor factors Spi1/Bcl11a.\",\n      \"evidence\": \"Hi-C, ChIP-seq, ATAC-seq, gain/loss-of-function in T cell progenitors; single-cell CRISPR disruption with scRNA-seq\",\n      \"pmids\": [\"35726060\", \"35594339\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TCF-1 directly recruits NIPBL/cohesin or this is an indirect consequence of chromatin opening\", \"Relative timing of TCF-1 vs. CTCF binding at remodeled TADs not established\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Whether specific cytokine signals maintain TCF-1+ stem-like cells in chronic infection remained incompletely mapped; IL-33–ST2 signaling was shown to be pivotal for expansion of stem-like TCF-1+ CD8+ T cells, with ST2 deficiency causing premature TCF-1 loss rescued by type I IFN blockade, and TGF-β was shown to maintain quiescence of TCF-1+ cells.\",\n      \"evidence\": \"ST2-KO mice with chronic LCMV, ATAC-seq, IFN blockade rescue; TGF-β receptor conditional KO with transcriptomics\",\n      \"pmids\": [\"36809763\", \"35980386\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether IL-33 directly induces Tcf7 transcription or acts through chromatin remodeling intermediates\", \"Integration of IL-33, TGF-β, and IL-10R signals at the single-cell level not resolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Major open questions include: the structural basis for TCF-1's pioneer-like chromatin remodeling activity, the complete set of direct transcriptional targets maintaining stem-like CD8+ T cells and ILC progenitors, how multiple cytokine inputs (IL-33, TGF-β, IL-10R) are integrated to regulate Tcf7 expression and TCF-1+ cell fate, and whether TCF-1's 3D genome reorganization via CTCF involves direct cohesin recruitment.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structural model of TCF-1 in complex with nucleosomal DNA\", \"Comprehensive direct target gene catalog in stem-like T cells lacking\", \"Signal integration logic at Tcf7 regulatory elements not defined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 1, 2, 6, 16, 36]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 3, 11, 13, 16, 19, 26]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 3, 19, 29]},\n      {\"term_id\": \"GO:0005694\", \"supporting_discovery_ids\": [19, 20, 27]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [5, 7, 8, 9, 32]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [3, 11, 13, 16, 19, 26]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [12, 19, 20, 27]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [10, 11, 18, 21, 40]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [7, 9, 11, 15, 38]}\n    ],\n    \"complexes\": [\n      \"β-catenin–TCF-1 transcriptional complex\"\n    ],\n    \"partners\": [\n      \"CTNNB1\",\n      \"CTCF\",\n      \"RUNX3\",\n      \"HEB\",\n      \"FOXP3\",\n      \"LEF1\",\n      \"UCH37\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}